| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | MYO5A DAG1 C2CD5 HMCN2 SULF1 ACAN PCDH19 LTBP4 VIL1 HSPG2 PCDHGA6 PCLO PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 RAB44 CELSR3 CELSR2 HMCN1 DCHS1 | 1.79e-05 | 749 | 213 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | protein antigen binding | 2.07e-05 | 16 | 213 | 4 | GO:1990405 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 6.44e-05 | 8 | 213 | 3 | GO:0098882 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | NACA DCC SRCAP CIITA QKI NCOA2 GTF2A1L CALCOCO1 LPIN3 BRD4 HELZ2 ELK1 | 1.06e-04 | 303 | 213 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | integrin binding | 1.13e-04 | 175 | 213 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 1.85e-04 | 11 | 213 | 3 | GO:0019870 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ADAM9 ITGA6 SIRPB1 ITGB4 SIRPG NEO1 PKP2 CX3CL1 LTBP4 FN1 PUF60 ADAMTS8 USO1 DCHS1 PRKCA PKN2 MADCAM1 | 2.49e-04 | 599 | 213 | 17 | GO:0050839 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | HMCN2 PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 HMCN1 DCHS1 ROBO1 IGSF21 | 7.43e-09 | 187 | 209 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MAG WNK1 HMCN2 PCDH19 CX3CL1 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 HMCN1 DCHS1 ROBO1 IGSF21 | 2.25e-08 | 313 | 209 | 17 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAG ADAM9 ITGA6 SIRPB1 DCC WNK1 ITGB4 FCHO1 SIRPG NEO1 HMCN2 PCDH19 PKP2 PLG CX3CL1 PCDHGA6 LAMA3 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 PBRM1 CELSR3 CELSR2 HMCN1 BRD4 DCHS1 PRKCA ROBO1 IGSF21 MADCAM1 | 4.38e-08 | 1077 | 209 | 32 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuron projection development | MAG ERCC6 HLA-F DAG1 ITGA6 GBX1 DCC NEO1 HMCN2 PTPRK PLD2 QKI CX3CL1 STRCP1 HSPG2 PRRX1 FN1 JADE2 LMTK2 LAMA3 PCDHAC2 LIMK1 PBRM1 CELSR3 CELSR2 MICALL2 PLXNA4 PRKCA ROBO1 RIMS2 PHACTR1 | 6.12e-06 | 1285 | 209 | 31 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | MAG ERCC6 HLA-F DAG1 ITGA6 GBX1 DCC WNK1 NEO1 HMCN2 PTPRK PLD2 QKI CX3CL1 STRCP1 HSPG2 PRRX1 SLC4A7 FN1 JADE2 LMTK2 LAMA3 PCDHAC2 LIMK1 PBRM1 CELSR3 CELSR2 MICALL2 PLXNA4 PRKCA ROBO1 RIMS2 PHACTR1 | 1.21e-05 | 1463 | 209 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 2.01e-05 | 6 | 209 | 3 | GO:0048790 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | ADAM9 DAG1 ITGA6 SIRPB1 ITGB4 SIRPG PTPRK PKP2 PLG CX3CL1 STRCP1 FN1 MICALL2 LPA MADCAM1 | 2.02e-05 | 410 | 209 | 15 | GO:0031589 |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion import across plasma membrane | 3.48e-05 | 7 | 209 | 3 | GO:1903288 | |
| GeneOntologyBiologicalProcess | axon guidance | DAG1 GBX1 DCC NEO1 HMCN2 HSPG2 LMTK2 LAMA3 PCDHAC2 CELSR3 PLXNA4 ROBO1 | 3.61e-05 | 285 | 209 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | DAG1 GBX1 DCC NEO1 HMCN2 HSPG2 LMTK2 LAMA3 PCDHAC2 CELSR3 PLXNA4 ROBO1 | 3.74e-05 | 286 | 209 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | regulation of potassium ion import | 8.24e-05 | 9 | 209 | 3 | GO:1903286 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MAG DAG1 GBX1 DCC NEO1 HMCN2 VIL1 HSPG2 FN1 JADE2 LMTK2 LAMA3 PCDHAC2 LIMK1 CELSR3 CELSR2 PLXNA4 PRKCA ROBO1 RIMS2 PHACTR1 | 9.37e-05 | 819 | 209 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | ADAM9 DAG1 ITGA6 SIRPB1 ITGB4 SIRPG PTPRK CX3CL1 STRCP1 FN1 MADCAM1 | 1.02e-04 | 270 | 209 | 11 | GO:0007160 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MAG DAG1 GBX1 DCC NEO1 HMCN2 VIL1 HSPG2 FN1 JADE2 LMTK2 LAMA3 PCDHAC2 LIMK1 CELSR3 CELSR2 PLXNA4 PRKCA ROBO1 RIMS2 PHACTR1 | 1.06e-04 | 826 | 209 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of I-kappaB phosphorylation | 1.17e-04 | 10 | 209 | 3 | GO:1903719 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 1.17e-04 | 10 | 209 | 3 | GO:1990709 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 1.29e-04 | 26 | 209 | 4 | GO:0099550 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MAG DAG1 GBX1 DCC NEO1 HMCN2 HSPG2 FN1 JADE2 LMTK2 LAMA3 PCDHAC2 LIMK1 CELSR3 CELSR2 PLXNA4 PRKCA ROBO1 RIMS2 PHACTR1 | 2.00e-04 | 802 | 209 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | MAG DAG1 GBX1 DCC NEO1 HMCN2 HSPG2 FN1 LMTK2 LAMA3 PCDHAC2 LIMK1 CELSR3 PLXNA4 PRKCA ROBO1 | 2.24e-04 | 566 | 209 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MAG DAG1 GBX1 DCC NEO1 HMCN2 STRCP1 HSPG2 FN1 LMTK2 LAMA3 PCDHAC2 LIMK1 CELSR3 CELSR2 PLXNA4 PRKCA ROBO1 PHACTR1 | 2.30e-04 | 748 | 209 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of anion channel activity | 3.05e-04 | 3 | 209 | 2 | GO:0010360 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 3.05e-04 | 3 | 209 | 2 | GO:0099526 | |
| GeneOntologyCellularComponent | basement membrane | DAG1 ITGA6 ITGB4 HMCN2 ACAN USH2A HSPG2 COL7A1 FN1 LAMA3 HMCN1 | 4.72e-08 | 122 | 212 | 11 | GO:0005604 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | DAG1 ITGA6 GDF10 ITGB4 HMCN2 SULF1 ACAN PLG USH2A LTBP4 HSPG2 COL7A1 FN1 LAMA3 ADAMTS8 HMCN1 LPA | 3.09e-05 | 530 | 212 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | chromatin | SETD1A SP1 SP4 ERCC6 GATAD2A BACH2 GON4L KLF3 GBX1 POGZ SRCAP CIC EBF2 CREB3L3 TAF4 SAP130 EBF4 NCOA2 KLF11 PRRX1 EBF3 JADE2 CALCOCO1 ADNP2 EBF1 RFX7 ATF6B PBRM1 BRD4 ELF2 ELK1 PAX4 | 3.93e-05 | 1480 | 212 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | external encapsulating structure | LRRC24 DAG1 ITGA6 GDF10 ITGB4 HMCN2 SULF1 ACAN PLG USH2A LTBP4 HSPG2 COL7A1 FN1 LAMA3 ADAMTS8 PKHD1L1 HMCN1 LPA | 4.41e-05 | 658 | 212 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 5.55e-05 | 8 | 212 | 3 | GO:0048788 | |
| GeneOntologyCellularComponent | anchoring junction | ADAM9 DAG1 ITGA6 PARD6G ITGB4 UBN1 PTPRK PKP2 WNK3 HSPG2 KLF11 LAMA3 PCDHA12 CAT PRX LIMK1 SHROOM1 HMCN1 MICALL2 XIRP2 MDC1 PRKCA PKN2 IGSF21 | 5.72e-05 | 976 | 212 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | extracellular matrix | LRRC24 DAG1 ITGA6 GDF10 ITGB4 HMCN2 SULF1 ACAN PLG USH2A LTBP4 HSPG2 COL7A1 FN1 LAMA3 ADAMTS8 HMCN1 LPA | 1.34e-04 | 656 | 212 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | hemidesmosome | 1.60e-04 | 11 | 212 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.61e-04 | 31 | 212 | 4 | GO:0060077 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.96e-04 | 32 | 212 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | adherens junction | 3.26e-04 | 212 | 212 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 3.45e-04 | 14 | 212 | 3 | GO:0099569 | |
| GeneOntologyCellularComponent | cell surface | LRRC24 ADAM9 HLA-F DAG1 ITGA6 SIRPB1 DCC ITGB4 SIRPG NEO1 PTPRK CIITA SULF1 PLG BSN CX3CL1 STRCP1 SLC26A9 LPA LRRC8A ROBO1 IGSF21 CEACAM20 FCMR | 3.99e-04 | 1111 | 212 | 24 | GO:0009986 |
| GeneOntologyCellularComponent | cell-cell junction | DAG1 ITGA6 PARD6G UBN1 PTPRK PKP2 WNK3 LAMA3 PCDHA12 SHROOM1 HMCN1 MICALL2 PRKCA PKN2 IGSF21 | 1.07e-03 | 591 | 212 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.57e-03 | 23 | 212 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.83e-03 | 86 | 212 | 5 | GO:0001673 | |
| GeneOntologyCellularComponent | axon | MAG MYO5A DAG1 IREB2 DCC NEO1 HMCN2 PTPRK BSN USH2A PCLO LMTK2 GRM4 LIMK1 MAST1 PRKCA ROBO1 ELK1 PUM1 | 1.88e-03 | 891 | 212 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | cell-substrate junction | ADAM9 DAG1 ITGA6 ITGB4 HSPG2 KLF11 LAMA3 CAT LIMK1 HMCN1 XIRP2 MDC1 | 1.97e-03 | 443 | 212 | 12 | GO:0030055 |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 1.53e-06 | 16 | 69 | 5 | HP:0010476 | |
| HumanPheno | Abnormality of the outer ear | SETD1A AARS1 ERCC6 DAG1 ITGA6 IREB2 POGZ SRCAP ITGB4 GREB1L CEP120 ACAN CC2D2A TAF4 ALG12 WNK3 HSPG2 COL7A1 PRRX1 IPO8 FN1 EBF3 PUF60 PCLO CHSY1 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 LRRC8A PUM1 SPEN PHACTR1 | 3.45e-06 | 1337 | 69 | 36 | HP:0000356 |
| HumanPheno | Abnormal location of ears | SETD1A DAG1 IREB2 POGZ SRCAP GREB1L CEP120 ACAN CC2D2A TAF4 WNK3 HSPG2 PRRX1 IPO8 FN1 EBF3 PUF60 PCLO CHSY1 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 LRRC8A PUM1 SPEN PHACTR1 | 4.71e-06 | 945 | 69 | 29 | HP:0000357 |
| HumanPheno | Abnormal pinna morphology | SETD1A AARS1 ERCC6 DAG1 ITGA6 IREB2 POGZ SRCAP ITGB4 GREB1L CEP120 ACAN CC2D2A TAF4 ALG12 WNK3 HSPG2 PRRX1 IPO8 FN1 EBF3 PUF60 PCLO CHSY1 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 LRRC8A PUM1 SPEN PHACTR1 | 5.35e-06 | 1299 | 69 | 35 | HP:0000377 |
| HumanPheno | Abnormal dermatological laboratory findings | 6.09e-06 | 10 | 69 | 4 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 6.09e-06 | 10 | 69 | 4 | HP:0003341 | |
| HumanPheno | Low-set ears | SETD1A DAG1 IREB2 POGZ SRCAP GREB1L CEP120 ACAN CC2D2A TAF4 WNK3 HSPG2 PRRX1 IPO8 EBF3 PCLO CHSY1 BRF1 CTCF OTUD6B BRD4 LRRC8A PUM1 SPEN PHACTR1 | 9.16e-06 | 761 | 69 | 25 | HP:0000369 |
| HumanPheno | Subepidermal blistering | 9.47e-06 | 11 | 69 | 4 | HP:0033804 | |
| HumanPheno | Prominent nasal bridge | ERCC6 SRCAP CEP120 CC2D2A TAF4 ALG12 HSPG2 IPO8 EBF3 CTCF OTUD6B PUM1 SPEN | 1.42e-05 | 239 | 69 | 13 | HP:0000426 |
| HumanPheno | Ventriculomegaly | MAG AARS1 ERCC6 DAG1 POGZ CEP120 PCDH19 CC2D2A PLG ALG12 HSPG2 EBF3 PUF60 PRX BRF1 CTCF OTUD6B BRD4 DCHS1 MAST1 ROBO1 CFAP74 PUM1 SPEN PHACTR1 | 1.79e-05 | 790 | 69 | 25 | HP:0002119 |
| HumanPheno | Blistering by histological location | 2.01e-05 | 13 | 69 | 4 | HP:0033801 | |
| HumanPheno | Aplasia of the bladder | 2.33e-05 | 5 | 69 | 3 | HP:0010477 | |
| HumanPheno | Abnormal male external genitalia morphology | SETD1A AARS1 ERCC6 DAG1 ITGA6 POGZ DCC SRCAP ITGB4 CEP120 CC2D2A TAF4 USH2A LTBP4 ALG12 WNK3 HSPG2 COL7A1 PRRX1 IPO8 EBF3 PUF60 LAMA3 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 ROBO1 PUM1 SPEN PHACTR1 | 2.75e-05 | 1329 | 69 | 34 | HP:0000032 |
| HumanPheno | Oral mucosal blisters | 2.79e-05 | 14 | 69 | 4 | HP:0200097 | |
| HumanPheno | Posteriorly rotated ears | DAG1 POGZ SRCAP CEP120 ACAN CC2D2A TAF4 HSPG2 PRRX1 IPO8 FN1 EBF3 PUF60 RFX7 LIMK1 CTCF BRD4 SPEN | 3.39e-05 | 470 | 69 | 18 | HP:0000358 |
| HumanPheno | Long palpebral fissure | 4.11e-05 | 71 | 69 | 7 | HP:0000637 | |
| HumanPheno | Abnormal external genitalia | SETD1A AARS1 ERCC6 DAG1 ITGA6 POGZ DCC SRCAP ITGB4 CEP120 CC2D2A TAF4 USH2A LTBP4 ALG12 WNK3 HSPG2 COL7A1 PRRX1 IPO8 EBF3 PUF60 LAMA3 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 ROBO1 PUM1 SPEN PHACTR1 | 5.62e-05 | 1372 | 69 | 34 | HP:0000811 |
| HumanPheno | Abnormality of the male genitalia | SETD1A AARS1 ERCC6 DAG1 ITGA6 POGZ DCC SRCAP ITGB4 CEP120 CC2D2A TAF4 USH2A LTBP4 ALG12 WNK3 HSPG2 COL7A1 PRRX1 IPO8 EBF3 PUF60 LAMA3 SLC26A9 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 ROBO1 PUM1 SPEN PHACTR1 | 5.78e-05 | 1437 | 69 | 35 | HP:0010461 |
| HumanPheno | Urethral stricture | 6.43e-05 | 17 | 69 | 4 | HP:0012227 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 8.01e-05 | 7 | 69 | 3 | HP:0020117 | |
| HumanPheno | Abnormal lower limb bone morphology | MAG AARS1 ERCC6 DAG1 SRCAP WNK1 CEP120 ACAN PCDH19 CC2D2A TAF4 ALG12 WNK3 HSPG2 IPO8 FN1 EBF3 PUF60 CHSY1 BRF1 CTCF BRD4 DCHS1 ROBO1 SPEN | 8.81e-05 | 866 | 69 | 25 | HP:0040069 |
| HumanPheno | Prominent nose | 1.02e-04 | 110 | 69 | 8 | HP:0000448 | |
| HumanPheno | Atrophy/Degeneration affecting the central nervous system | MAG AARS1 ERCC6 MYO5A DAG1 POGZ CEP120 PCDH19 GM2A CC2D2A TAF4 PLG USH2A ALG12 WNK3 HSPG2 PRRX1 EBF3 PUF60 PCLO RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 MAST1 ROBO1 SNAPC4 PUM1 SPEN PHACTR1 | 1.03e-04 | 1347 | 69 | 33 | HP:0007367 |
| HumanPheno | Abnormal morphology of bones of the lower limbs | ERCC6 SRCAP CEP120 ACAN PCDH19 TAF4 ALG12 WNK3 HSPG2 FN1 EBF3 PUF60 CHSY1 BRF1 CTCF DCHS1 | 1.16e-04 | 422 | 69 | 16 | HP:0040066 |
| HumanPheno | Abnormal size of the palpebral fissures | ERCC6 SRCAP TAF4 HSPG2 IPO8 PUF60 PCLO RFX7 LIMK1 CTCF OTUD6B DCHS1 SPEN | 1.43e-04 | 298 | 69 | 13 | HP:0200007 |
| HumanPheno | Abnormal toe morphology | AARS1 ERCC6 WNK1 ITGB4 CIC CEP120 ACAN CC2D2A TAF4 LTBP4 ALG12 HSPG2 IPO8 EBF3 PUF60 CHSY1 RFX7 PRX LIMK1 CTCF OTUD6B BRD4 ROBO1 PUM1 SPEN | 1.47e-04 | 893 | 69 | 25 | HP:0001780 |
| HumanPheno | Aplasia/Hypoplasia of the cerebellum | ERCC6 MYO5A DAG1 CEP120 CC2D2A TAF4 PLG USH2A ALG12 PRRX1 EBF3 PCLO RFX7 BRF1 BRD4 DCHS1 MAST1 ROBO1 PUM1 | 1.71e-04 | 581 | 69 | 19 | HP:0007360 |
| HumanPheno | Recurrent loss of toenails and fingernails | 1.81e-04 | 2 | 69 | 2 | HP:0008390 | |
| HumanPheno | Hydronephrosis | ERCC6 ITGA6 SRCAP ITGB4 GREB1L LTBP4 HSPG2 IPO8 LAMA3 RFX7 BRF1 SPEN | 1.82e-04 | 264 | 69 | 12 | HP:0000126 |
| HumanPheno | Long fingers | WNK1 CIC ALG12 IPO8 EBF3 PUF60 RFX7 BRF1 CTCF OTUD6B BRD4 PUM1 SPEN | 1.87e-04 | 306 | 69 | 13 | HP:0100807 |
| HumanPheno | Congenital localized absence of skin | 1.89e-04 | 9 | 69 | 3 | HP:0007383 | |
| HumanPheno | Mitten deformity | 1.89e-04 | 9 | 69 | 3 | HP:0004057 | |
| HumanPheno | Inguinal hernia | POGZ SRCAP CC2D2A TAF4 LTBP4 WNK3 HSPG2 IPO8 PUF60 LIMK1 BRF1 CTCF BRD4 | 2.27e-04 | 312 | 69 | 13 | HP:0000023 |
| HumanPheno | Abnormal upper lip morphology | SETD1A AARS1 ERCC6 IREB2 POGZ SRCAP GREB1L CEP120 CC2D2A TAF4 LTBP4 ALG12 HSPG2 EBF3 PUF60 PCLO CHSY1 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 ROBO1 SPEN | 2.51e-04 | 980 | 69 | 26 | HP:0000177 |
| HumanPheno | Abnormal midface morphology | SETD1A IREB2 POGZ SRCAP CEP120 ACAN CC2D2A LTBP4 ALG12 HSPG2 IPO8 FN1 PUF60 PCLO CHSY1 RFX7 LIMK1 BRF1 CTCF DCHS1 SPEN | 2.60e-04 | 704 | 69 | 21 | HP:0000309 |
| HumanPheno | Urethral obstruction | 3.04e-04 | 69 | 69 | 6 | HP:0000796 | |
| HumanPheno | Abnormal larynx morphology | 3.25e-04 | 201 | 69 | 10 | HP:0025423 | |
| HumanPheno | Restricted or repetitive behaviors or interests | POGZ SRCAP CIC PCDH19 TAF4 HSPG2 EBF3 PUF60 RFX7 LIMK1 CTCF BRD4 PUM1 SPEN | 3.26e-04 | 368 | 69 | 14 | HP:0031432 |
| HumanPheno | Renal cyst | SRCAP GREB1L CEP120 CC2D2A HSPG2 KLF11 PUF60 LAMA3 LIMK1 BRD4 PAX4 SPEN | 3.48e-04 | 283 | 69 | 12 | HP:0000107 |
| HumanPheno | Narrow palpebral fissure | 3.55e-04 | 71 | 69 | 6 | HP:0045025 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 3.63e-04 | 11 | 69 | 3 | HP:0032449 | |
| HumanPheno | Blistering by anatomical location | 3.68e-04 | 26 | 69 | 4 | HP:0033800 | |
| HumanPheno | Ectropion | 3.83e-04 | 72 | 69 | 6 | HP:0000656 | |
| HumanPheno | Gastroesophageal reflux | AARS1 ERCC6 POGZ SRCAP WNK1 LTBP4 ALG12 HSPG2 COL7A1 IPO8 EBF3 PUF60 SLC26A9 LIMK1 CTCF BRD4 SPEN | 3.87e-04 | 517 | 69 | 17 | HP:0002020 |
| HumanPheno | Highly arched eyebrow | 3.96e-04 | 206 | 69 | 10 | HP:0002553 | |
| HumanPheno | Abnormality of the philtrum | AARS1 ERCC6 IREB2 POGZ SRCAP TAF4 LTBP4 ALG12 HSPG2 EBF3 PUF60 PCLO CHSY1 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 ROBO1 SPEN | 4.00e-04 | 726 | 69 | 21 | HP:0000288 |
| HumanPheno | Perseverative thought | POGZ SRCAP CIC PCDH19 TAF4 HSPG2 EBF3 PUF60 RFX7 LIMK1 CTCF BRD4 PUM1 SPEN | 4.18e-04 | 377 | 69 | 14 | HP:0030223 |
| HumanPheno | Dilatation of the renal pelvis | ERCC6 ITGA6 SRCAP ITGB4 GREB1L LTBP4 HSPG2 IPO8 LAMA3 RFX7 BRF1 SPEN | 4.35e-04 | 290 | 69 | 12 | HP:0010946 |
| HumanPheno | Abnormal finger morphology | AARS1 ERCC6 POGZ SRCAP WNK1 ITGB4 CIC CEP120 CIITA ACAN CC2D2A TAF4 ALG12 WNK3 HSPG2 COL7A1 IPO8 FN1 EBF3 PUF60 LAMA3 CHSY1 RFX7 LIMK1 BRF1 CTCF OTUD6B BRD4 ROBO1 CFAP74 PUM1 SPEN | 4.60e-04 | 1385 | 69 | 32 | HP:0001167 |
| HumanPheno | Abnormal dermoepidermal junction morphology | 4.80e-04 | 12 | 69 | 3 | HP:0031538 | |
| HumanPheno | Abnormality of the ureter | ERCC6 ITGA6 POGZ ITGB4 GREB1L CC2D2A TAF4 HSPG2 EBF3 PUF60 LAMA3 LIMK1 BRF1 BRD4 | 4.91e-04 | 383 | 69 | 14 | HP:0000069 |
| HumanPheno | Abnormal finger phalanx morphology | ERCC6 POGZ SRCAP WNK1 CEP120 CIITA ACAN CC2D2A TAF4 HSPG2 IPO8 FN1 PUF60 CHSY1 BRF1 CTCF OTUD6B BRD4 ROBO1 PUM1 SPEN | 5.02e-04 | 738 | 69 | 21 | HP:0005918 |
| HumanPheno | Abnormality of the tubular bones | POGZ SRCAP CEP120 ACAN CC2D2A ALG12 HSPG2 IPO8 FN1 EBF3 PUF60 CHSY1 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 ROBO1 | 5.11e-04 | 632 | 69 | 19 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | POGZ SRCAP CEP120 ACAN CC2D2A ALG12 HSPG2 IPO8 FN1 EBF3 PUF60 CHSY1 LIMK1 BRF1 CTCF OTUD6B BRD4 DCHS1 ROBO1 | 5.11e-04 | 632 | 69 | 19 | HP:0100714 |
| HumanPheno | Disordered formal thought process | POGZ SRCAP CIC PCDH19 TAF4 HSPG2 EBF3 PUF60 RFX7 LIMK1 CTCF BRD4 PUM1 SPEN | 5.31e-04 | 386 | 69 | 14 | HP:0025769 |
| HumanPheno | Congenital pyloric atresia | 5.38e-04 | 3 | 69 | 2 | HP:0004399 | |
| HumanPheno | Infancy onset short-trunk short stature | 5.38e-04 | 3 | 69 | 2 | HP:0011406 | |
| HumanPheno | Abnormal stomach morphology | AARS1 ERCC6 ITGA6 POGZ DCC SRCAP WNK1 ITGB4 LTBP4 ALG12 HSPG2 COL7A1 IPO8 EBF3 PUF60 LAMA3 SLC26A9 LIMK1 CTCF BRD4 SPEN | 5.41e-04 | 742 | 69 | 21 | HP:0002577 |
| HumanPheno | Abnormality of the pylorus | 5.48e-04 | 107 | 69 | 7 | HP:0004400 | |
| HumanPheno | Maladaptive fear-related cognitions | SETD1A POGZ SRCAP CIC PCDH19 GM2A USH2A HSPG2 COL7A1 EBF3 SLC26A9 RFX7 LIMK1 CTCF BRD4 RIMS2 | 5.51e-04 | 483 | 69 | 16 | HP:5200230 |
| HumanPheno | Anxiety | SETD1A POGZ SRCAP CIC PCDH19 GM2A USH2A HSPG2 COL7A1 EBF3 SLC26A9 RFX7 LIMK1 CTCF BRD4 RIMS2 | 5.51e-04 | 483 | 69 | 16 | HP:0000739 |
| HumanPheno | Abnormality of the dentition | SETD1A AARS1 ERCC6 ITGA6 DCC SRCAP ITGB4 CEP120 TAF4 PLG USH2A WNK3 HSPG2 COL7A1 FN1 PUF60 LAMA3 CHSY1 CAT LIMK1 BRF1 CTCF BRD4 DCHS1 PUM1 SPEN | 5.68e-04 | 1030 | 69 | 26 | HP:0000164 |
| HumanPheno | Abnormal renal pelvis morphology | ERCC6 ITGA6 SRCAP ITGB4 GREB1L LTBP4 HSPG2 IPO8 LAMA3 RFX7 BRF1 SPEN | 5.92e-04 | 300 | 69 | 12 | HP:0010944 |
| HumanPheno | Diagnostic behavioral phenotype | SETD1A AARS1 IREB2 POGZ SRCAP CIC PCDH19 CC2D2A TAF4 USH2A HSPG2 PUF60 CAT RFX7 LIMK1 CTCF OTUD6B BRD4 RIMS2 SPEN PHACTR1 | 5.92e-04 | 747 | 69 | 21 | HP:0025783 |
| HumanPheno | Macrodontia of permanent maxillary central incisor | 6.17e-04 | 13 | 69 | 3 | HP:0000675 | |
| HumanPheno | Aplasia/Hypoplasia of the ear | 6.43e-04 | 219 | 69 | 10 | HP:0008771 | |
| HumanPheno | Abnormal cerebral ventricle morphology | MAG AARS1 ERCC6 DAG1 POGZ DCC CEP120 PCDH19 CC2D2A PLG ALG12 HSPG2 EBF3 PUF60 PRX BRF1 CTCF OTUD6B BRD4 DCHS1 MAST1 ROBO1 CFAP74 PUM1 SPEN PHACTR1 | 7.28e-04 | 1046 | 69 | 26 | HP:0002118 |
| HumanPheno | Abnormality of the upper respiratory tract | AARS1 ERCC6 BACH2 DCC SRCAP FCHO1 GREB1L CIITA ACAN PLG LTBP4 ALG12 HSPG2 PRRX1 PUF60 LAMA3 SLC26A9 CAT RFX7 PRX LIMK1 BRF1 BRD4 DCHS1 LRRC8A ROBO1 CFAP74 | 7.82e-04 | 1111 | 69 | 27 | HP:0002087 |
| HumanPheno | Abnormality of refraction | MAG AARS1 ERCC6 MYO5A DAG1 POGZ SRCAP CC2D2A TAF4 USH2A HSPG2 IPO8 FN1 EBF3 PUF60 LIMK1 CTCF BRD4 ROBO1 SPEN | 8.03e-04 | 709 | 69 | 20 | HP:0000539 |
| HumanPheno | Dystrophic fingernails | 8.33e-04 | 32 | 69 | 4 | HP:0008391 | |
| HumanPheno | Abnormal thought pattern | POGZ SRCAP CIC PCDH19 TAF4 HSPG2 EBF3 PUF60 RFX7 LIMK1 CTCF BRD4 PUM1 SPEN | 8.39e-04 | 404 | 69 | 14 | HP:5200269 |
| HumanPheno | Hernia of the abdominal wall | AARS1 POGZ SRCAP CEP120 CC2D2A TAF4 LTBP4 WNK3 HSPG2 IPO8 PUF60 RFX7 LIMK1 BRF1 CTCF BRD4 | 9.21e-04 | 506 | 69 | 16 | HP:0004299 |
| HumanPheno | Abnormality of the chin | ERCC6 POGZ SRCAP ACAN TAF4 HSPG2 FN1 EBF3 PUF60 RFX7 LIMK1 CTCF PUM1 SPEN | 9.48e-04 | 409 | 69 | 14 | HP:0000306 |
| HumanPheno | Urethral stenosis | 9.56e-04 | 57 | 69 | 5 | HP:0008661 | |
| HumanPheno | Abnormal tracheobronchial morphology | AARS1 ERCC6 BACH2 FCHO1 GREB1L ACAN LTBP4 PRRX1 SLC26A9 RFX7 LIMK1 DCHS1 LRRC8A CFAP74 | 9.71e-04 | 410 | 69 | 14 | HP:0005607 |
| HumanPheno | Abnormal renal morphology | ERCC6 ITGA6 POGZ DCC SRCAP ITGB4 GREB1L CEP120 CC2D2A PLG LTBP4 OPLAH HSPG2 KLF11 COL7A1 IPO8 FN1 EBF3 PUF60 LAMA3 SLC26A9 RFX7 LIMK1 BRF1 BRD4 DCHS1 ROBO1 PAX4 SPEN | 1.01e-03 | 1252 | 69 | 29 | HP:0012210 |
| HumanPheno | Abnormal testis morphology | SETD1A AARS1 ERCC6 DAG1 POGZ DCC SRCAP CEP120 CC2D2A TAF4 USH2A LTBP4 ALG12 WNK3 HSPG2 IPO8 EBF3 PUF60 LIMK1 BRF1 CTCF OTUD6B BRD4 ROBO1 PUM1 SPEN PHACTR1 | 1.02e-03 | 1129 | 69 | 27 | HP:0000035 |
| HumanPheno | Abdominal wall defect | AARS1 POGZ SRCAP CEP120 CC2D2A TAF4 LTBP4 WNK3 HSPG2 IPO8 PUF60 RFX7 LIMK1 BRF1 CTCF BRD4 | 1.02e-03 | 511 | 69 | 16 | HP:0010866 |
| HumanPheno | Thoracoabdominal wall defect | AARS1 POGZ SRCAP CEP120 CC2D2A TAF4 LTBP4 WNK3 HSPG2 IPO8 PUF60 RFX7 LIMK1 BRF1 CTCF BRD4 | 1.02e-03 | 511 | 69 | 16 | HP:0100656 |
| HumanPheno | Pes planus | DCC CIC PCDH19 TAF4 HSPG2 IPO8 EBF3 PUF60 PRX LIMK1 BRF1 CTCF SPEN | 1.03e-03 | 365 | 69 | 13 | HP:0001763 |
| HumanPheno | Cryptorchidism | AARS1 ERCC6 DAG1 DCC SRCAP CEP120 CC2D2A TAF4 ALG12 WNK3 HSPG2 EBF3 LIMK1 BRF1 CTCF OTUD6B BRD4 ROBO1 PUM1 SPEN PHACTR1 | 1.06e-03 | 780 | 69 | 21 | HP:0000028 |
| HumanPheno | Non-obstructive azoospermia | SETD1A AARS1 ERCC6 DAG1 POGZ DCC SRCAP CEP120 CC2D2A TAF4 USH2A LTBP4 ALG12 WNK3 HSPG2 IPO8 EBF3 PUF60 LIMK1 BRF1 CTCF OTUD6B BRD4 ROBO1 PUM1 SPEN PHACTR1 | 1.06e-03 | 1132 | 69 | 27 | HP:0011961 |
| HumanPheno | Short long bone | SRCAP CEP120 ALG12 HSPG2 FN1 EBF3 PUF60 CHSY1 BRD4 DCHS1 ROBO1 | 1.12e-03 | 278 | 69 | 11 | HP:0003026 |
| HumanPheno | Abnormal judgment | SETD1A POGZ SRCAP CIC PCDH19 GM2A USH2A HSPG2 COL7A1 EBF3 SLC26A9 RFX7 LIMK1 CTCF BRD4 RIMS2 | 1.14e-03 | 516 | 69 | 16 | HP:5200401 |
| HumanPheno | Incisor macrodontia | 1.17e-03 | 16 | 69 | 3 | HP:0011081 | |
| HumanPheno | Oval face | 1.17e-03 | 16 | 69 | 3 | HP:0000300 | |
| HumanPheno | Compulsive behaviors | 1.20e-03 | 158 | 69 | 8 | HP:0000722 | |
| HumanPheno | Autistic behavior | SETD1A AARS1 IREB2 POGZ SRCAP CIC PCDH19 CC2D2A TAF4 HSPG2 PUF60 RFX7 LIMK1 CTCF OTUD6B BRD4 RIMS2 SPEN PHACTR1 | 1.23e-03 | 678 | 69 | 19 | HP:0000729 |
| HumanPheno | Atrophy/Degeneration affecting the cerebrum | MAG AARS1 ERCC6 MYO5A POGZ PCDH19 GM2A USH2A WNK3 HSPG2 PUF60 PCLO LIMK1 CTCF OTUD6B BRD4 SNAPC4 PUM1 SPEN PHACTR1 | 1.23e-03 | 733 | 69 | 20 | HP:0007369 |
| HumanPheno | Abnormal intestine morphology | SETD1A ERCC6 BACH2 ITGA6 POGZ DCC SRCAP ITGB4 FCHO1 GREB1L CEP120 CIITA CC2D2A TAF4 PLG LTBP4 ALG12 OPLAH HSPG2 COL7A1 IPO8 LAMA3 SLC26A9 RFX7 LIMK1 CTCF OTUD6B BRD4 LRRC8A ROBO1 CFAP74 SPEN | 1.23e-03 | 1459 | 69 | 32 | HP:0002242 |
| HumanPheno | Abnormal hand morphology | ERCC6 SRCAP WNK1 ITGB4 CEP120 ACAN CC2D2A TAF4 ALG12 WNK3 HSPG2 COL7A1 FN1 EBF3 PUF60 LAMA3 CHSY1 PRX LIMK1 BRF1 CTCF BRD4 DCHS1 ROBO1 PUM1 SPEN | 1.24e-03 | 1082 | 69 | 26 | HP:0005922 |
| HumanPheno | Abnormal cerebellar vermis morphology | MYO5A DAG1 CEP120 CC2D2A TAF4 PLG EBF3 RFX7 BRF1 DCHS1 MAST1 ROBO1 PUM1 | 1.29e-03 | 374 | 69 | 13 | HP:0002334 |
| HumanPheno | Clinodactyly | SRCAP TAF4 ALG12 WNK3 HSPG2 FN1 EBF3 PUF60 CHSY1 RFX7 LIMK1 BRF1 CTCF BRD4 DCHS1 PUM1 SPEN | 1.29e-03 | 574 | 69 | 17 | HP:0030084 |
| MousePheno | proctitis | 7.51e-06 | 4 | 174 | 3 | MP:0003305 | |
| Domain | Ig-like_fold | MAG LRRC24 HLA-F DAG1 SIRPB1 DCC ITGB4 SIRPG EBF2 NEO1 HMCN2 PTPRK VSIG10L MYBPHL USH2A EBF4 HSPG2 COL7A1 FN1 EBF3 EBF1 PKHD1L1 IFNGR2 HMCN1 PLXNA4 ROBO1 IGSF21 CEACAM20 MADCAM1 FCMR | 1.79e-10 | 706 | 204 | 30 | IPR013783 |
| Domain | - | MAG LRRC24 HLA-F DAG1 SIRPB1 DCC ITGB4 SIRPG EBF2 NEO1 PTPRK VSIG10L MYBPHL USH2A EBF4 HSPG2 COL7A1 FN1 EBF3 EBF1 PKHD1L1 IFNGR2 HMCN1 PLXNA4 ROBO1 IGSF21 CEACAM20 MADCAM1 FCMR | 1.90e-10 | 663 | 204 | 29 | 2.60.40.10 |
| Domain | COE | 1.38e-08 | 4 | 204 | 4 | PS01345 | |
| Domain | Transcription_factor_COE | 1.38e-08 | 4 | 204 | 4 | IPR003523 | |
| Domain | COE_HLH | 1.38e-08 | 4 | 204 | 4 | IPR032201 | |
| Domain | COE_DBD | 1.38e-08 | 4 | 204 | 4 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 1.38e-08 | 4 | 204 | 4 | IPR018350 | |
| Domain | COE1_HLH | 1.38e-08 | 4 | 204 | 4 | PF16423 | |
| Domain | COE1_DBD | 1.38e-08 | 4 | 204 | 4 | PF16422 | |
| Domain | Cadherin-like | DAG1 PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 5.83e-08 | 116 | 204 | 11 | IPR015919 |
| Domain | Cadherin_CS | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 3.23e-07 | 109 | 204 | 10 | IPR020894 |
| Domain | IPT | 3.86e-07 | 27 | 204 | 6 | SM00429 | |
| Domain | CADHERIN_1 | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 4.53e-07 | 113 | 204 | 10 | PS00232 |
| Domain | Cadherin | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 4.53e-07 | 113 | 204 | 10 | PF00028 |
| Domain | CADHERIN_2 | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 4.92e-07 | 114 | 204 | 10 | PS50268 |
| Domain | - | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 4.92e-07 | 114 | 204 | 10 | 2.60.40.60 |
| Domain | CA | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 5.34e-07 | 115 | 204 | 10 | SM00112 |
| Domain | Cadherin | PCDH19 PCDHGA6 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 CELSR3 CELSR2 DCHS1 | 6.78e-07 | 118 | 204 | 10 | IPR002126 |
| Domain | TIG | 9.25e-07 | 31 | 204 | 6 | PF01833 | |
| Domain | IPT | 1.13e-06 | 32 | 204 | 6 | IPR002909 | |
| Domain | Cadherin_tail | 2.77e-06 | 37 | 204 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 2.77e-06 | 37 | 204 | 6 | IPR031904 | |
| Domain | IG | MAG LRRC24 SIRPB1 DCC SIRPG NEO1 HMCN2 PTPRK VSIG10L MYBPHL HSPG2 HMCN1 ROBO1 IGSF21 CEACAM20 MADCAM1 FCMR | 4.00e-06 | 421 | 204 | 17 | SM00409 |
| Domain | Ig_sub | MAG LRRC24 SIRPB1 DCC SIRPG NEO1 HMCN2 PTPRK VSIG10L MYBPHL HSPG2 HMCN1 ROBO1 IGSF21 CEACAM20 MADCAM1 FCMR | 4.00e-06 | 421 | 204 | 17 | IPR003599 |
| Domain | Cadherin_2 | 6.81e-06 | 65 | 204 | 7 | PF08266 | |
| Domain | Cadherin_N | 6.81e-06 | 65 | 204 | 7 | IPR013164 | |
| Domain | IG_LIKE | MAG LRRC24 HLA-F SIRPB1 DCC SIRPG NEO1 HMCN2 PTPRK VSIG10L MYBPHL HSPG2 HMCN1 ROBO1 IGSF21 CEACAM20 MADCAM1 FCMR | 7.87e-06 | 491 | 204 | 18 | PS50835 |
| Domain | Ig_I-set | MAG LRRC24 DCC NEO1 HMCN2 PTPRK MYBPHL HSPG2 HMCN1 ROBO1 CEACAM20 | 7.98e-06 | 190 | 204 | 11 | IPR013098 |
| Domain | I-set | MAG LRRC24 DCC NEO1 HMCN2 PTPRK MYBPHL HSPG2 HMCN1 ROBO1 CEACAM20 | 7.98e-06 | 190 | 204 | 11 | PF07679 |
| Domain | Ig-like_dom | MAG LRRC24 HLA-F SIRPB1 DCC SIRPG NEO1 HMCN2 PTPRK VSIG10L MYBPHL HSPG2 HMCN1 ROBO1 IGSF21 CEACAM20 MADCAM1 FCMR | 1.09e-05 | 503 | 204 | 18 | IPR007110 |
| Domain | fn3 | 1.19e-05 | 162 | 204 | 10 | PF00041 | |
| Domain | EGF_LAM_2 | 1.69e-05 | 30 | 204 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 1.69e-05 | 30 | 204 | 5 | PS01248 | |
| Domain | OSR1_C | 2.51e-05 | 6 | 204 | 3 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.51e-05 | 6 | 204 | 3 | IPR024678 | |
| Domain | EGF_Lam | 3.68e-05 | 35 | 204 | 5 | SM00180 | |
| Domain | Laminin_EGF | 3.68e-05 | 35 | 204 | 5 | PF00053 | |
| Domain | FN3 | 3.74e-05 | 185 | 204 | 10 | SM00060 | |
| Domain | LAM_G_DOMAIN | 5.54e-05 | 38 | 204 | 5 | PS50025 | |
| Domain | Laminin_EGF | 5.54e-05 | 38 | 204 | 5 | IPR002049 | |
| Domain | IGc2 | MAG LRRC24 DCC NEO1 HMCN2 VSIG10L MYBPHL HSPG2 HMCN1 ROBO1 CEACAM20 | 5.72e-05 | 235 | 204 | 11 | SM00408 |
| Domain | Ig_sub2 | MAG LRRC24 DCC NEO1 HMCN2 VSIG10L MYBPHL HSPG2 HMCN1 ROBO1 CEACAM20 | 5.72e-05 | 235 | 204 | 11 | IPR003598 |
| Domain | FN3 | 6.91e-05 | 199 | 204 | 10 | PS50853 | |
| Domain | Laminin_G_2 | 7.14e-05 | 40 | 204 | 5 | PF02210 | |
| Domain | FN3_dom | 1.04e-04 | 209 | 204 | 10 | IPR003961 | |
| Domain | LamG | 1.14e-04 | 44 | 204 | 5 | SM00282 | |
| Domain | EGF_1 | ADAM9 ITGB4 HMCN2 USH2A LTBP4 HSPG2 FN1 LAMA3 CELSR3 CELSR2 HMCN1 | 1.18e-04 | 255 | 204 | 11 | PS00022 |
| Domain | ATP_synth_su_G_mt_met | 1.19e-04 | 2 | 204 | 2 | IPR016702 | |
| Domain | Neogenin_C | 1.19e-04 | 2 | 204 | 2 | IPR010560 | |
| Domain | BMP3/BMP3B | 1.19e-04 | 2 | 204 | 2 | IPR017197 | |
| Domain | Neogenin_C | 1.19e-04 | 2 | 204 | 2 | PF06583 | |
| Domain | ATP-synt_G | 1.19e-04 | 2 | 204 | 2 | PF04718 | |
| Domain | Znf_piccolo | 1.19e-04 | 2 | 204 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.19e-04 | 2 | 204 | 2 | PF05715 | |
| Domain | ATP_synth_F0_gsu_mt | 1.19e-04 | 2 | 204 | 2 | IPR006808 | |
| Domain | C2 | 1.32e-04 | 137 | 204 | 8 | SM00239 | |
| Domain | - | 2.25e-04 | 148 | 204 | 8 | 2.60.40.150 | |
| Domain | Qua1_dom | 3.54e-04 | 3 | 204 | 2 | IPR032571 | |
| Domain | Sam68-YY | 3.54e-04 | 3 | 204 | 2 | IPR032335 | |
| Domain | Sam68-YY | 3.54e-04 | 3 | 204 | 2 | PF16568 | |
| Domain | Qua1 | 3.54e-04 | 3 | 204 | 2 | PF16274 | |
| Domain | Laminin_G | 4.24e-04 | 58 | 204 | 5 | IPR001791 | |
| Domain | C2_dom | 4.50e-04 | 164 | 204 | 8 | IPR000008 | |
| Domain | C2 | 5.96e-04 | 131 | 204 | 7 | PF00168 | |
| Domain | EGF-like_CS | 6.14e-04 | 261 | 204 | 10 | IPR013032 | |
| Domain | G2F | 7.02e-04 | 4 | 204 | 2 | PF07474 | |
| Domain | RNase_II/R_CS | 7.02e-04 | 4 | 204 | 2 | IPR022966 | |
| Domain | NIDOGEN_G2 | 7.02e-04 | 4 | 204 | 2 | PS50993 | |
| Domain | GFP | 7.02e-04 | 4 | 204 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 7.02e-04 | 4 | 204 | 2 | IPR006605 | |
| Domain | C2 | 9.60e-04 | 142 | 204 | 7 | PS50004 | |
| Domain | Ig_E-set | 9.85e-04 | 104 | 204 | 6 | IPR014756 | |
| Domain | Pkinase_C | 1.12e-03 | 42 | 204 | 4 | PF00433 | |
| Domain | NUT | 1.16e-03 | 5 | 204 | 2 | IPR024310 | |
| Domain | NUT_N | 1.16e-03 | 5 | 204 | 2 | IPR024309 | |
| Domain | NUT | 1.16e-03 | 5 | 204 | 2 | PF12881 | |
| Domain | ig | 1.18e-03 | 190 | 204 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.18e-03 | 190 | 204 | 8 | IPR013151 | |
| Domain | IGv | 1.38e-03 | 75 | 204 | 5 | SM00406 | |
| Domain | Ig_V-set | 1.58e-03 | 199 | 204 | 8 | IPR013106 | |
| Domain | Growth_fac_rcpt_ | 1.65e-03 | 156 | 204 | 7 | IPR009030 | |
| Domain | Myb-like_dom | 1.73e-03 | 6 | 204 | 2 | IPR017877 | |
| Domain | VWFA | 2.04e-03 | 82 | 204 | 5 | PS50234 | |
| Domain | EGF_CA | 2.23e-03 | 122 | 204 | 6 | SM00179 | |
| Domain | VWA | 2.27e-03 | 84 | 204 | 5 | SM00327 | |
| Domain | EGF-like_Ca-bd_dom | 2.42e-03 | 124 | 204 | 6 | IPR001881 | |
| Domain | EGF_2 | 2.61e-03 | 265 | 204 | 9 | PS01186 | |
| Domain | LAMININ_IVA | 3.18e-03 | 8 | 204 | 2 | PS51115 | |
| Domain | Laminin_B | 3.18e-03 | 8 | 204 | 2 | PF00052 | |
| Domain | LamB | 3.18e-03 | 8 | 204 | 2 | SM00281 | |
| Domain | Laminin_IV | 3.18e-03 | 8 | 204 | 2 | IPR000034 | |
| Domain | AGC-kinase_C | 3.26e-03 | 56 | 204 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.26e-03 | 56 | 204 | 4 | PS51285 | |
| Domain | S_TK_X | 3.26e-03 | 56 | 204 | 4 | SM00133 | |
| Domain | - | 3.87e-03 | 95 | 204 | 5 | 2.60.120.200 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.19e-06 | 59 | 144 | 7 | M27218 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM9 DAG1 ITGA6 ITGB4 ACAN PLG LTBP4 HSPG2 COL7A1 FN1 LAMA3 ADAMTS8 PRKCA MADCAM1 | 2.38e-06 | 300 | 144 | 14 | M610 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.20e-05 | 30 | 144 | 5 | M27216 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 9.37e-05 | 140 | 144 | 8 | M587 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 1.38e-04 | 49 | 144 | 5 | M92 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.53e-04 | 27 | 144 | 4 | M27217 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.62e-04 | 11 | 144 | 3 | M27372 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.62e-04 | 11 | 144 | 3 | M158 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.16e-04 | 84 | 144 | 6 | M7098 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION | 2.77e-04 | 13 | 144 | 3 | M47674 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 3.01e-04 | 32 | 144 | 4 | M165 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 3.39e-04 | 33 | 144 | 4 | M39503 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.50e-04 | 14 | 144 | 3 | MM14923 | |
| Pathway | WP_ADIPOGENESIS | 3.90e-04 | 131 | 144 | 7 | M39505 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 4.46e-04 | 96 | 144 | 6 | MM14592 | |
| Pathway | WP_ADIPOGENESIS_GENES | 5.11e-04 | 137 | 144 | 7 | MM15970 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 SETD1A LRRC24 VWA8 ATG2A SRCAP WNK1 ITGB4 CIC PLEKHH3 GGA3 ZCCHC14 TNRC18 UBN1 LTBP4 WNK2 HSPG2 ZNF628 PUF60 LMTK2 CHSY1 LPIN3 LATS2 CELSR3 CELSR2 BRD4 HELZ2 SNAPC4 PUM1 SPEN DHX34 | 2.02e-12 | 1105 | 214 | 31 | 35748872 |
| Pubmed | SP1 SP4 HIVEP1 BACH2 KLF3 POGZ SRCAP CIC ZCCHC14 CREB3L3 NCOA2 KLF11 PRRX1 EBF3 EBF1 PKHD1L1 ATF6B ARID3B LIMK1 PBRM1 MBNL2 CTCF BRD4 ELF2 ELK1 SNAPC4 | 7.18e-12 | 808 | 214 | 26 | 20412781 | |
| Pubmed | SETD1A VWA8 NACA POGZ ATG2A GGA3 LRRC47 RBM27 SULF1 BSN WNK2 JADE2 LMTK2 CHSY1 DIS3 UBE2O CELSR3 MDC1 LRRC8A RIMS2 DHX34 | 1.84e-11 | 529 | 214 | 21 | 14621295 | |
| Pubmed | Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. | 1.39e-09 | 4 | 214 | 4 | 12139918 | |
| Pubmed | HIVEP1 WNK1 ITGB4 CIC KIAA1549L CREB3L3 QKI LTBP4 BAG6 WNK2 KPNA1 HSPG2 KLF11 IPO8 PUF60 SCAMP1 CALCOCO1 BRF1 PUM1 SPEN | 1.49e-09 | 608 | 214 | 20 | 16713569 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A SP1 SP4 ATG2A WNK1 CIC TASOR2 GGA3 TNRC18 UBN1 BSN SAP130 WNK2 PRX XIRP2 MDC1 SPEN | 1.77e-09 | 430 | 214 | 17 | 35044719 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | AARS1 HIVEP1 GATAD2A BACH2 GON4L POGZ TNRC18 NCOA2 PCLO ADNP2 CAT ARID3B PBRM1 BRD4 ELK1 NUTM2F | 4.26e-09 | 398 | 214 | 16 | 35016035 |
| Pubmed | 6.94e-09 | 5 | 214 | 4 | 15261831 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 ERCC6 GATAD2A POGZ SRCAP CIC UBN1 TAF4 KPNA1 ADNP2 ARID3B ATP5MG UBE2O PBRM1 BRD4 MDC1 ELF2 SNAPC4 SPEN | 8.94e-09 | 608 | 214 | 19 | 36089195 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.54e-08 | 72 | 214 | 8 | 10380929 | |
| Pubmed | 2.40e-08 | 15 | 214 | 5 | 15640798 | ||
| Pubmed | MON2 ERCC6 GATAD2A VWA8 BACH2 POGZ SIRPB1 SRCAP C2CD5 HMCN2 ACTL8 PCDH19 PKP2 TAF4 LTBP4 SAP130 KPNA1 ADNP2 PBRM1 TRMT2A CTCF TRABD CBY2 BRD4 DHX34 | 2.96e-08 | 1116 | 214 | 25 | 31753913 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.48e-08 | 150 | 214 | 10 | 28242625 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.57e-08 | 80 | 214 | 8 | 10716726 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 4.81e-08 | 7 | 214 | 4 | 24786561 | |
| Pubmed | alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. | 4.81e-08 | 7 | 214 | 4 | 9151677 | |
| Pubmed | 4.90e-08 | 17 | 214 | 5 | 29911975 | ||
| Pubmed | The Transcription Factors EBF1 and EBF2 Are Positive Regulators of Myelination in Schwann Cells. | 4.90e-08 | 17 | 214 | 5 | 27889898 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 6.76e-08 | 18 | 214 | 5 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 6.76e-08 | 18 | 214 | 5 | 10662547 | |
| Pubmed | SETD1A SP1 HIVEP1 GATAD2A MYO5A NACA GON4L KLF3 POGZ SRCAP CIC UBN1 RBM27 TAF4 QKI SAP130 NCOA2 HSPG2 SCAF8 RFX7 ARID3B UBE2O PBRM1 CTCF MDC1 ELF2 PUM1 SPEN | 6.92e-08 | 1429 | 214 | 28 | 35140242 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 6.97e-08 | 58 | 214 | 7 | 30377227 | |
| Pubmed | LRRC24 MYO5A ADAM9 SIRPB1 SIRPG TAF4 BSN WNK3 WNK2 KPNA1 NCOA2 EBF3 CALCOCO1 GRM4 ATF6B UBE2O PBRM1 CELSR2 CTCF DCHS1 PRKCA PHACTR1 | 1.52e-07 | 963 | 214 | 22 | 28671696 | |
| Pubmed | 1.58e-07 | 21 | 214 | 5 | 27856617 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 9151732 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 20544851 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 35137272 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP1 SP4 HIVEP1 BACH2 GON4L GBX1 CIC CREB3L3 EBF4 KLF11 PRRX1 EBF3 ADNP2 EBF1 RFX7 ATF6B CTCF ELF2 ELK1 PAX4 SNAPC4 | 2.41e-07 | 908 | 214 | 21 | 19274049 |
| Pubmed | 3.25e-07 | 24 | 214 | 5 | 20826655 | ||
| Pubmed | 3.25e-07 | 24 | 214 | 5 | 24698270 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 4.45e-07 | 11 | 214 | 4 | 9655502 | |
| Pubmed | Analysis of Netrin 1 receptors during inner ear development. | 4.45e-07 | 11 | 214 | 4 | 17616930 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 GATAD2A IREB2 DCC SRCAP WNK1 BMP3 HSPG2 FN1 DIS3 PBRM1 OTUD6B PUM1 | 4.68e-07 | 363 | 214 | 13 | 14691545 |
| Pubmed | 5.05e-07 | 77 | 214 | 7 | 10835267 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | GATAD2A NACA LRRC47 SAP130 HSPG2 SCAF8 ARID3B PBRM1 BRD4 MDC1 | 5.87e-07 | 203 | 214 | 10 | 22083510 |
| Pubmed | 6.64e-07 | 12 | 214 | 4 | 30658714 | ||
| Pubmed | Transient and lineage-restricted requirement of Ebf3 for sternum ossification. | 6.64e-07 | 12 | 214 | 4 | 32398354 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 7.37e-07 | 28 | 214 | 5 | 15347688 | |
| Pubmed | 8.46e-07 | 83 | 214 | 7 | 28794006 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 9151733 | ||
| Pubmed | WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. | 9.15e-07 | 4 | 214 | 3 | 11571656 | |
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 11498583 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 21900290 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 17673510 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 34384519 | ||
| Pubmed | HIVEP1 CIC TNRC18 RBM27 SAP130 NCOA2 ARID3B PBRM1 BRD4 MDC1 ELF2 | 9.71e-07 | 268 | 214 | 11 | 33640491 | |
| Pubmed | 1.03e-06 | 167 | 214 | 9 | 22159717 | ||
| Pubmed | SP1 DAG1 WNK2 PCDHA12 PCDHA7 PCDHA5 PRX CELSR3 CELSR2 BRD4 RIMS2 SPEN | 1.08e-06 | 329 | 214 | 12 | 17474147 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.41e-06 | 57 | 214 | 6 | 32633719 | |
| Pubmed | 1.47e-06 | 90 | 214 | 7 | 30228991 | ||
| Pubmed | 1.48e-06 | 32 | 214 | 5 | 23154389 | ||
| Pubmed | 1.52e-06 | 175 | 214 | 9 | 28071719 | ||
| Pubmed | SETD1A POGZ SRCAP GGA3 RBM27 TAF4 SAP130 NCOA2 PUF60 ARID3B UBE2O BRD4 MDC1 PKN2 SPEN | 1.84e-06 | 549 | 214 | 15 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A HIVEP1 KLF3 POGZ TNRC18 TAF4 NCOA2 RFX7 PBRM1 MDC1 ELF2 SPEN | 2.11e-06 | 351 | 214 | 12 | 38297188 |
| Pubmed | SP1 HIVEP1 BACH2 KLF3 POGZ CIC ZCCHC14 NCOA2 KLF11 PRRX1 EBF3 JADE2 EBF1 LIMK1 PBRM1 BRD4 PAX4 | 2.20e-06 | 709 | 214 | 17 | 22988430 | |
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 2.28e-06 | 5 | 214 | 3 | 9271670 | |
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 12917357 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 32296015 | ||
| Pubmed | Detailed physical and genetic mapping in the region of plasminogen, D17Rp17e, and quaking. | 2.28e-06 | 5 | 214 | 3 | 8111116 | |
| Pubmed | Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. | 2.28e-06 | 5 | 214 | 3 | 16061471 | |
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 16436605 | ||
| Pubmed | Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. | 2.28e-06 | 5 | 214 | 3 | 16870608 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 2.39e-06 | 16 | 214 | 4 | 17948866 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 2.39e-06 | 16 | 214 | 4 | 21067603 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SP1 CIC CIITA EBF4 NCOA2 PRRX1 GTF2A1L EBF3 JADE2 CALCOCO1 EBF1 ARID3B BRF1 CARF ELF2 ELK1 SNAPC4 SPEN FCMR | 2.42e-06 | 877 | 214 | 19 | 20211142 |
| Pubmed | AARS1 MYO5A POGZ TASOR2 LRRC47 UTP20 FN1 PUF60 DIS3 UBE2O PBRM1 CTCF MDC1 HELZ2 PUM1 SPEN | 3.35e-06 | 653 | 214 | 16 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A AARS1 ERCC6 GATAD2A MYO5A NACA POGZ SRCAP LRRC47 UBN1 PKP2 UTP20 BAG6 KPNA1 FN1 MYO19 ADNP2 CAT DIS3 MDC1 PRKCA PKN2 PUM1 DHX34 | 3.61e-06 | 1353 | 214 | 24 | 29467282 |
| Pubmed | 3.67e-06 | 146 | 214 | 8 | 27068509 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 4.03e-06 | 68 | 214 | 6 | 11230163 | |
| Pubmed | 4.53e-06 | 6 | 214 | 3 | 9389446 | ||
| Pubmed | Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. | 4.53e-06 | 6 | 214 | 3 | 12529443 | |
| Pubmed | A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). | 4.53e-06 | 6 | 214 | 3 | 2138612 | |
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 4.53e-06 | 6 | 214 | 3 | 30758284 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 4.94e-06 | 202 | 214 | 9 | 33601422 | |
| Pubmed | SP4 AARS1 HIVEP1 GATAD2A POGZ CIC TNRC18 RBM27 TAF4 QKI SAP130 BAG6 NCOA2 IPO8 EBF3 PUF60 ARID3B BRD4 CSTF3 ELF2 SPEN | 5.24e-06 | 1103 | 214 | 21 | 34189442 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 6.61e-06 | 74 | 214 | 6 | 10817752 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 HIVEP1 POGZ CIC C2CD5 UBN1 UTP20 BAG6 SCAF8 RFX7 BRD4 MDC1 HELZ2 ELF2 PKN2 SNAPC4 SPEN | 6.98e-06 | 774 | 214 | 17 | 15302935 |
| Pubmed | NACA RBM27 PLD2 SAP130 BAG6 IPO8 PCLO EBF1 ARID3B PBRM1 MDC1 SPEN | 7.20e-06 | 396 | 214 | 12 | 26687479 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AARS1 HIVEP1 RIMKLA WNK1 CIC ZCCHC14 MYLK3 FAM83G PKP2 WNK3 SLC4A7 LMTK2 RFX7 LPIN3 LIMK1 USO1 BRD4 PUM1 | 7.30e-06 | 861 | 214 | 18 | 36931259 |
| Pubmed | Multi-omics profiling visualizes dynamics of cardiac development and functions. | 7.90e-06 | 7 | 214 | 3 | 36577384 | |
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 20525693 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 GATAD2A POGZ CIC TASOR2 UBN1 RBM27 TAF4 SAP130 PUF60 ARID3B MBNL2 CTCF BRD4 MDC1 CSTF3 ELF2 PUM1 SPEN | 8.02e-06 | 954 | 214 | 19 | 36373674 |
| Pubmed | MON2 ADAM9 GON4L POGZ GGA3 KLHL29 ZCCHC14 PCDH19 SCAF8 MAST1 PUM1 SPEN | 9.47e-06 | 407 | 214 | 12 | 12693553 | |
| Pubmed | 1.26e-05 | 8 | 214 | 3 | 23387299 | ||
| Pubmed | 1.26e-05 | 8 | 214 | 3 | 14993187 | ||
| Pubmed | 1.26e-05 | 8 | 214 | 3 | 23838290 | ||
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 1.59e-05 | 25 | 214 | 4 | 15820306 | |
| Pubmed | Tissue-specific regulation of Igf2r/Airn imprinting during gastrulation. | 1.88e-05 | 9 | 214 | 3 | 25918552 | |
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 1.88e-05 | 9 | 214 | 3 | 23144817 | |
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 12482924 | ||
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 12154121 | ||
| Pubmed | BACH2 DAG1 GON4L IREB2 TASOR2 PLIN2 GREB1L ZCCHC14 TNRC18 UBN1 SULF1 FAM83G ZNHIT2 OPLAH NCOA2 PUF60 CC2D1B PLBD2 PUM1 RIMS2 DHX34 | 2.22e-05 | 1215 | 214 | 21 | 15146197 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ADAM9 DAG1 PARD6G C2CD5 PTPRK NIBAN1 SLC4A7 SCAMP1 LATS2 ROBO1 PKN2 | 2.46e-05 | 377 | 214 | 11 | 38117590 |
| Pubmed | 2.67e-05 | 10 | 214 | 3 | 11163266 | ||
| Pubmed | 2.79e-05 | 251 | 214 | 9 | 29031500 | ||
| Pubmed | 2.81e-05 | 193 | 214 | 8 | 22589738 | ||
| Pubmed | 2.93e-05 | 29 | 214 | 4 | 23499423 | ||
| Pubmed | 2.93e-05 | 29 | 214 | 4 | 39289460 | ||
| Pubmed | 2.93e-05 | 29 | 214 | 4 | 22613833 | ||
| Pubmed | MYO5A DCC SRCAP TASOR2 TNRC18 CC2D2A TAF4 BSN VIL1 PCDHGA6 PCLO KHDRBS2 CC2D1B CAT PRX ATP5MG LATS2 KHDRBS3 PLXNA4 CFAP74 RIMS2 SPEN FCMR | 3.13e-05 | 1442 | 214 | 23 | 35575683 | |
| Interaction | NFYC interactions | SETD1A SP1 SP4 HIVEP1 GON4L POGZ CIC TAF4 KLF11 ADNP2 RFX7 ATF6B PBRM1 PAX4 NUTM2F | 4.86e-10 | 177 | 208 | 15 | int:NFYC |
| Interaction | HNF4A interactions | SETD1A SP1 HIVEP1 POGZ SRCAP CIC UBN1 TAF4 SAP130 NCOA2 ARID3B PBRM1 ELF2 SPEN | 1.10e-06 | 275 | 208 | 14 | int:HNF4A |
| Interaction | TAF3 interactions | 3.57e-06 | 88 | 208 | 8 | int:TAF3 | |
| Interaction | KLF3 interactions | SETD1A HIVEP1 GATAD2A KLF3 POGZ CIC TAF4 SAP130 RFX7 ARID3B PBRM1 ELF2 | 4.65e-06 | 228 | 208 | 12 | int:KLF3 |
| Interaction | ELF1 interactions | 6.49e-06 | 126 | 208 | 9 | int:ELF1 | |
| Interaction | TOP3B interactions | MON2 SETD1A LRRC24 VWA8 IREB2 ATG2A SRCAP WNK1 ITGB4 CIC PLEKHH3 GGA3 ZCCHC14 TNRC18 UBN1 PKP2 LTBP4 WNK2 HSPG2 ZNF628 PUF60 LMTK2 CHSY1 LPIN3 LATS2 CELSR3 CELSR2 BRD4 MDC1 HELZ2 SNAPC4 PUM1 SPEN DHX34 | 7.51e-06 | 1470 | 208 | 34 | int:TOP3B |
| Interaction | NFIC interactions | HIVEP1 KLF3 POGZ CIC ZCCHC14 SAP130 ARID3B LATS2 BRD4 MDC1 ELF2 | 1.22e-05 | 210 | 208 | 11 | int:NFIC |
| Interaction | TERF2IP interactions | SETD1A HIVEP1 GATAD2A POGZ SRCAP CIC TASOR2 RBM27 TAF4 SAP130 NCOA2 PUF60 PRX CTCF BRD4 MDC1 ELF2 SPEN | 1.80e-05 | 552 | 208 | 18 | int:TERF2IP |
| Interaction | NFIX interactions | SETD1A HIVEP1 POGZ SRCAP CIC TAF4 SAP130 ARID3B PBRM1 ELF2 SPEN | 2.52e-05 | 227 | 208 | 11 | int:NFIX |
| Interaction | FBXO2 interactions | ADAM9 DAG1 ITGA6 PTPRK SULF1 LTBP4 HSPG2 SLC4A7 FN1 LAMA3 ATF6B PLBD2 CELSR3 ROBO1 PAX4 | 2.56e-05 | 411 | 208 | 15 | int:FBXO2 |
| Interaction | BAG2 interactions | SETD1A SP1 WNK1 CIC RBM27 PLD2 QKI WNK3 REC8 NCOA2 FN1 SHROOM1 LATS2 BRD4 MDC1 CSTF3 ELK1 PUM1 SPEN | 2.59e-05 | 622 | 208 | 19 | int:BAG2 |
| Interaction | EBF4 interactions | 3.68e-05 | 7 | 208 | 3 | int:EBF4 | |
| Interaction | ASF1A interactions | HIVEP1 GATAD2A POGZ SRCAP TASOR2 UBN1 SAP130 BRF1 MDC1 ELF2 SPEN | 5.85e-05 | 249 | 208 | 11 | int:ASF1A |
| Interaction | EBF3 interactions | 6.97e-05 | 22 | 208 | 4 | int:EBF3 | |
| Interaction | PCDHA10 interactions | 6.97e-05 | 22 | 208 | 4 | int:PCDHA10 | |
| Interaction | TAF12 interactions | 8.02e-05 | 100 | 208 | 7 | int:TAF12 | |
| Interaction | SCP2 interactions | 8.51e-05 | 70 | 208 | 6 | int:SCP2 | |
| Interaction | H3-3A interactions | SETD1A HIVEP1 ERCC6 GATAD2A POGZ SRCAP CIC UBN1 TAF4 SAP130 KPNA1 PUF60 ADNP2 ARID3B PBRM1 BRD4 MDC1 ELF2 SNAPC4 SPEN | 1.02e-04 | 749 | 208 | 20 | int:H3-3A |
| Interaction | SP4 interactions | 1.08e-04 | 46 | 208 | 5 | int:SP4 | |
| Interaction | SUDS3 interactions | 1.10e-04 | 141 | 208 | 8 | int:SUDS3 | |
| Interaction | SNRNP40 interactions | HIVEP1 GATAD2A GON4L POGZ TASOR2 UBN1 TAF4 QKI ZNHIT2 HSPG2 SCAF8 ADNP2 ARID3B CTCF BRD4 MDC1 CSTF3 SPEN | 1.14e-04 | 637 | 208 | 18 | int:SNRNP40 |
| Interaction | CD160 interactions | 1.33e-04 | 48 | 208 | 5 | int:CD160 | |
| Interaction | PCDHGB1 interactions | 1.45e-04 | 77 | 208 | 6 | int:PCDHGB1 | |
| Interaction | CYP1A1 interactions | 1.45e-04 | 77 | 208 | 6 | int:CYP1A1 | |
| Interaction | MAFF interactions | 1.47e-04 | 49 | 208 | 5 | int:MAFF | |
| Interaction | SIN3B interactions | 1.47e-04 | 147 | 208 | 8 | int:SIN3B | |
| Interaction | TLE3 interactions | HIVEP1 KLF3 CIC TNRC18 GM2A TAF4 QKI SAP130 NCOA2 EBF3 SCAF8 BRD4 SPEN | 1.53e-04 | 376 | 208 | 13 | int:TLE3 |
| Interaction | KLF8 interactions | SETD1A SP1 HIVEP1 POGZ CIC TAF4 SAP130 NCOA2 PBRM1 CTCF ELF2 SPEN | 1.68e-04 | 329 | 208 | 12 | int:KLF8 |
| Cytoband | 5q31 | 1.72e-05 | 115 | 213 | 6 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 5.27e-05 | 16 | 213 | 3 | chr6q26 | |
| Cytoband | 6q26 | 7.63e-05 | 18 | 213 | 3 | 6q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 8.37e-05 | 298 | 213 | 8 | chr5q31 | |
| GeneFamily | Fibronectin type III domain containing | 6.17e-07 | 160 | 144 | 10 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.54e-07 | 161 | 144 | 10 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | DCC NEO1 HMCN2 PTPRK VSIG10L HSPG2 IGSF21 CEACAM20 MADCAM1 FCMR | 3.39e-06 | 193 | 144 | 10 | 594 |
| GeneFamily | Clustered protocadherins | 1.18e-05 | 64 | 144 | 6 | 20 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.88e-04 | 3 | 144 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.88e-04 | 3 | 144 | 2 | 1189 | |
| GeneFamily | Signal transduction and activation of RNA metabolism family | 1.88e-04 | 3 | 144 | 2 | 1275 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 6.20e-04 | 5 | 144 | 2 | 747 | |
| GeneFamily | PDZ domain containing | 1.38e-03 | 152 | 144 | 6 | 1220 | |
| GeneFamily | Fibulins | 1.71e-03 | 8 | 144 | 2 | 556 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.19e-03 | 9 | 144 | 2 | 755 | |
| GeneFamily | C2 domain containing protein kinases | 2.72e-03 | 10 | 144 | 2 | 835 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.91e-03 | 36 | 144 | 3 | 823 | |
| GeneFamily | C1-set domain containing | 4.53e-03 | 42 | 144 | 3 | 591 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 6.18e-03 | 15 | 144 | 2 | 26 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GALNT15 SP4 MYO5A BACH2 DCC C2CD5 EBF2 KIAA1549L PTPRK PCDH19 BSN WNK3 EBF3 PCLO KHDRBS2 LAMA3 PCDHA7 EBF1 RFX7 GRM4 BRF1 CELSR3 KHDRBS3 PLXNA4 MAST1 PRKCA ROBO1 RIMS2 | 8.48e-08 | 1106 | 211 | 28 | M39071 |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN | 1.59e-06 | 45 | 211 | 6 | M13714 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | ITGA6 PARD6G ITGB4 KLHL29 SULF1 PCDH19 QKI LTBP4 HSPG2 COL7A1 PRRX1 EBF3 LAMA3 PRX DCHS1 | 8.71e-06 | 479 | 211 | 15 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | ITGA6 PARD6G ITGB4 KLHL29 SULF1 PCDH19 QKI LTBP4 HSPG2 COL7A1 PRRX1 EBF3 LAMA3 PRX DCHS1 | 9.61e-06 | 483 | 211 | 15 | MM1082 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | MAG SP1 DAG1 ITGA6 FCHO1 BMP3 NEO1 SULF1 PKP2 ZNHIT2 REC8 HSPG2 MYO19 PCLO LAMA3 PCDHAC2 ADAMTS8 PKHD1L1 KHDRBS3 LRRC8A PHACTR1 | 3.24e-05 | 955 | 211 | 21 | M45680 |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP | 3.46e-05 | 198 | 211 | 9 | M4478 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_UP | 3.74e-05 | 200 | 211 | 9 | M5195 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP | 3.74e-05 | 200 | 211 | 9 | M6836 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 3.74e-05 | 200 | 211 | 9 | M6842 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | GON4L KLF3 WNK1 RBM27 PRRX1 ZNF628 ADNP2 CAT RFX7 DIS3 KHDRBS3 BRD4 LSP1 PUM1 | 4.16e-05 | 484 | 211 | 14 | MM999 |
| Coexpression | HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP | 5.92e-05 | 10 | 211 | 3 | M14215 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | MYO5A ITGA6 KLHL35 DCC PKP2 EBF3 EBF1 GRM4 CELSR3 MAST1 ROBO1 | 7.69e-05 | 328 | 211 | 11 | M39064 |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ITGB4 KLHL29 SULF1 LTBP4 REC8 VIL1 TCAF2 HSPG2 PKHD1L1 MICALL2 PLXNA4 DCHS1 CFAP74 | 8.83e-12 | 190 | 213 | 13 | 3cf464664d6aa22b212e60b70885953887e92483 |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | EBF2 KLHL29 HMCN2 SULF1 LTBP4 PRRX1 SLC4A7 FN1 EBF1 KHDRBS3 ROBO1 | 2.67e-09 | 194 | 213 | 11 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.49e-08 | 187 | 213 | 10 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.70e-08 | 195 | 213 | 10 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-07 | 185 | 213 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-07 | 189 | 213 | 9 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 3.53e-07 | 190 | 213 | 9 | 3d45d5011305f13634013d9eeb98f235517dd54e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.69e-07 | 191 | 213 | 9 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.69e-07 | 191 | 213 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.03e-07 | 193 | 213 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-07 | 195 | 213 | 9 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.43e-07 | 200 | 213 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 172 | 213 | 8 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 172 | 213 | 8 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 172 | 213 | 8 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-06 | 182 | 213 | 8 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-06 | 182 | 213 | 8 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-06 | 185 | 213 | 8 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.28e-06 | 186 | 213 | 8 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 186 | 213 | 8 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.41e-06 | 187 | 213 | 8 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-06 | 187 | 213 | 8 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.55e-06 | 188 | 213 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-06 | 188 | 213 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-small_pre-B-II_cell|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.55e-06 | 188 | 213 | 8 | 56d78b5a86a71b2e752db379f4a46dc4c623b553 | |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.55e-06 | 188 | 213 | 8 | 9acb7a95e3095f15918a5d094107d1d565a42842 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.69e-06 | 189 | 213 | 8 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 190 | 213 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 190 | 213 | 8 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 3.84e-06 | 190 | 213 | 8 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 190 | 213 | 8 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 190 | 213 | 8 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-06 | 191 | 213 | 8 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.99e-06 | 191 | 213 | 8 | 2b05be1888cccd03a32341bcb1de4a899d4179fd | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.31e-06 | 193 | 213 | 8 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-06 | 193 | 213 | 8 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.31e-06 | 193 | 213 | 8 | cf4ba50aa4a00d1ba22fc7626d49a4104377d5d9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.48e-06 | 194 | 213 | 8 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-06 | 197 | 213 | 8 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.20e-06 | 198 | 213 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Sigmoid-(2)_B_cell-(23)_Follicular_B_cell|Sigmoid / shred on region, Cell_type, and subtype | 5.20e-06 | 198 | 213 | 8 | bfb1aa1450d1afb14b875e0cf6796e1a715b4605 | |
| ToppCell | Sigmoid-B_cell-Follicular_B_cell|Sigmoid / Region, Cell class and subclass | 5.20e-06 | 198 | 213 | 8 | c3507fb508ace85a31dcff323f9e7ddb9ae6862e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.60e-06 | 200 | 213 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 5.60e-06 | 200 | 213 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 101 | 213 | 6 | af4a84e4993d4e80c834e1591556b3b3781deaf3 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.52e-06 | 154 | 213 | 7 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 158 | 213 | 7 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 160 | 213 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 160 | 213 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-13|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-05 | 162 | 213 | 7 | 28b3a6ae5519a267eefb70436d3190a387d027b9 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-05 | 164 | 213 | 7 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | LA-04._Ventricular_Cardiomyocyte_I|LA / Chamber and Cluster_Paper | 1.49e-05 | 110 | 213 | 6 | 34dcd1e1e16e8b6088ff9a7a40532e8bd000c121 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-05 | 167 | 213 | 7 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 168 | 213 | 7 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 169 | 213 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.95e-05 | 172 | 213 | 7 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 173 | 213 | 7 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 174 | 213 | 7 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 174 | 213 | 7 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 174 | 213 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 174 | 213 | 7 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 175 | 213 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 213 | 7 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 176 | 213 | 7 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 176 | 213 | 7 | 045b12c90f7dd49a9778dadcdf8f18125b380531 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-05 | 177 | 213 | 7 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.52e-05 | 179 | 213 | 7 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-05 | 180 | 213 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.61e-05 | 180 | 213 | 7 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-05 | 180 | 213 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 2.61e-05 | 180 | 213 | 7 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 181 | 213 | 7 | 59527ad218e49386b04cabb97d53d2ed55a35961 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.70e-05 | 181 | 213 | 7 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 2.80e-05 | 182 | 213 | 7 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.80e-05 | 182 | 213 | 7 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 183 | 213 | 7 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 183 | 213 | 7 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 183 | 213 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 183 | 213 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 183 | 213 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 183 | 213 | 7 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.90e-05 | 183 | 213 | 7 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.00e-05 | 184 | 213 | 7 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 3.11e-05 | 185 | 213 | 7 | 1c99373c123b5e0de40b47d9d885974a747b9839 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 3.11e-05 | 185 | 213 | 7 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 185 | 213 | 7 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 185 | 213 | 7 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-05 | 186 | 213 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-pre-B-I_cell|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.22e-05 | 186 | 213 | 7 | d708e8f3e371c8249e8e8f7458b352af7be412e6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 3.22e-05 | 186 | 213 | 7 | a5c0bd4f6a7542f67d478dcdc0645ae6d927a395 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Naive_B_cells|Liver / Manually curated celltypes from each tissue | 3.22e-05 | 186 | 213 | 7 | 23efdcedbe67f5e6c59106e052f570cd0338f1c1 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-05 | 186 | 213 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.33e-05 | 187 | 213 | 7 | 55aad84b992412e487a32f4970620189a7380ba6 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.33e-05 | 187 | 213 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-05 | 187 | 213 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.44e-05 | 188 | 213 | 7 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.44e-05 | 188 | 213 | 7 | 7b56c680e9f1851cb961b0f8faeeb987685ae36d | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | MON2 SRCAP CEP68 ACAN GM2A NCOA2 TRMT2A MBNL2 PRKCA DHX34 FCMR | 2.10e-06 | 196 | 209 | 11 | 6653_DN |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A | SETD1A NACA GON4L SRCAP GREB1L QKI LIMK1 CELSR2 MBNL2 DHX34 MADCAM1 | 2.10e-06 | 196 | 209 | 11 | 1494_UP |
| Drug | DB04780 | 4.06e-06 | 170 | 209 | 10 | CID005459389 | |
| Drug | YIGSR | 8.23e-06 | 79 | 209 | 7 | CID000123977 | |
| Drug | B-Ms | 1.06e-05 | 114 | 209 | 8 | CID000445091 | |
| Drug | kalinin | 1.11e-05 | 55 | 209 | 6 | CID000032518 | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.30e-05 | 194 | 209 | 10 | 2223_UP | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.38e-05 | 155 | 209 | 9 | 6817_DN | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A | 1.42e-05 | 196 | 209 | 10 | 6367_DN | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.42e-05 | 196 | 209 | 10 | 4824_UP | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.42e-05 | 196 | 209 | 10 | 4984_DN | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.49e-05 | 197 | 209 | 10 | 5866_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | SETD1A KLF3 ITGB4 HSPG2 SLC4A7 FN1 CALCOCO1 LIMK1 TRABD DHX34 | 1.49e-05 | 197 | 209 | 10 | 4295_DN |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 209 | 10 | 6475_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 209 | 10 | 5408_DN | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | GON4L GGA3 ZCCHC14 GM2A NCOA2 HSPG2 FN1 KHDRBS2 PCDHA5 DHX34 | 1.49e-05 | 197 | 209 | 10 | 3453_UP |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 209 | 10 | 5475_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 1.62e-05 | 199 | 209 | 10 | 6364_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | SETD1A GON4L KLF3 SRCAP FCHO1 ALG12 NCOA2 KHDRBS2 CELSR2 MICALL2 | 1.62e-05 | 199 | 209 | 10 | 2683_DN |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; PC3; HT_HG-U133A | 1.62e-05 | 199 | 209 | 10 | 6645_DN | |
| Drug | AC1L9INI | 1.67e-05 | 59 | 209 | 6 | CID000445839 | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 3.77e-05 | 176 | 209 | 9 | 6179_DN | |
| Drug | P-O-O | 4.12e-05 | 69 | 209 | 6 | CID004369535 | |
| Drug | NSC53670 | 5.04e-05 | 44 | 209 | 5 | CID000243583 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 5.11e-05 | 183 | 209 | 9 | 5599_UP | |
| Drug | poly(N-isopropylacrylamide | 5.33e-05 | 23 | 209 | 4 | CID000016637 | |
| Drug | Laminin peptide 11 | 6.15e-05 | 9 | 209 | 3 | CID000219027 | |
| Drug | Gdrgdsp | 6.71e-05 | 109 | 209 | 7 | CID000115346 | |
| Drug | AC1L1C2F | 7.11e-05 | 110 | 209 | 7 | CID000001711 | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 7.70e-05 | 193 | 209 | 9 | 866_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 7.70e-05 | 193 | 209 | 9 | 7490_UP | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 7.70e-05 | 193 | 209 | 9 | 4978_UP | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.70e-05 | 193 | 209 | 9 | 7409_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HG-U133A | 8.01e-05 | 194 | 209 | 9 | 258_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 8.33e-05 | 195 | 209 | 9 | 5024_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 10uM; MCF7; HG-U133A | 8.33e-05 | 195 | 209 | 9 | 405_DN | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 4551_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 4439_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 5536_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 3311_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 4160_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 7533_UP | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 4832_UP | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 2241_UP | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 7213_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 6815_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 7239_UP | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 2636_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 5446_UP | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; PC3; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4183_UP | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4609_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4805_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4701_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4592_DN | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 4087_DN | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 7532_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 4765_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 6775_UP | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 1.01e-04 | 200 | 209 | 9 | 2704_UP | |
| Drug | BM165 | 1.19e-04 | 11 | 209 | 3 | CID003352881 | |
| Drug | Antigens, Polyomavirus Transforming | SP1 SP4 NACA GON4L POGZ WNK1 TNRC18 PTPRK QKI ZNHIT2 NCOA2 LMTK2 EBF1 TRMT2A MBNL2 HELZ2 ELF2 | 1.55e-04 | 668 | 209 | 17 | ctd:D000952 |
| Disease | pulse pressure measurement | GATAD2A POGZ SRCAP GDF10 PLIN2 EBF2 KLHL29 CEP68 CEP120 KIAA1549L BAG6 SLC4A7 FN1 PCDHA12 PCDHA7 PCDHA5 PCDHA4 EBF1 ADAMTS8 GRM4 LIMK1 PBRM1 LATS2 KHDRBS3 OTUD6B LSP1 PKN2 DHX34 PHACTR1 | 1.07e-07 | 1392 | 203 | 29 | EFO_0005763 |
| Disease | 1,5 anhydroglucitol measurement | 1.52e-06 | 29 | 203 | 5 | EFO_0008009 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 6.32e-06 | 6 | 203 | 3 | DOID:4479 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.10e-05 | 7 | 203 | 3 | DOID:3209 (is_implicated_in) | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.10e-05 | 7 | 203 | 3 | EFO_0004614, EFO_0006925 | |
| Disease | Prostatic Neoplasms | ADAM9 DAG1 PTPRK CX3CL1 REC8 NCOA2 PRRX1 JADE2 LMTK2 ADAMTS8 USO1 CTCF BRD4 ROBO1 SPEN | 2.64e-05 | 616 | 203 | 15 | C0033578 |
| Disease | vital capacity | DCC CEP120 SULF1 ACAN GM2A LTBP4 HSPG2 PRRX1 IPO8 ZNF628 FN1 JADE2 PCLO PCDHA12 PCDHA7 PCDHA5 PCDHA4 EBF1 ADAMTS8 HMCN1 BRD4 SNAPC4 | 4.67e-05 | 1236 | 203 | 22 | EFO_0004312 |
| Disease | junctional epidermolysis bullosa with pyloric atresia (is_implicated_in) | 4.71e-05 | 2 | 203 | 2 | DOID:0060733 (is_implicated_in) | |
| Disease | Intellectual Disability | SETD1A GON4L POGZ DCC CIC QKI PUF60 BRF1 CTCF BRD4 PUM1 PHACTR1 | 6.86e-05 | 447 | 203 | 12 | C3714756 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.58e-05 | 34 | 203 | 4 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 8.58e-05 | 34 | 203 | 4 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | Malignant neoplasm of prostate | ADAM9 DAG1 PTPRK CX3CL1 REC8 NCOA2 PRRX1 JADE2 LMTK2 ADAMTS8 USO1 BRD4 ROBO1 SPEN | 1.02e-04 | 616 | 203 | 14 | C0376358 |
| Disease | Epidermolysis bullosa with pyloric atresia | 1.41e-04 | 3 | 203 | 2 | C1856934 | |
| Disease | neogenin measurement | 1.41e-04 | 3 | 203 | 2 | EFO_0801823 | |
| Disease | Schizophrenia | MAG SETD1A SP1 SP4 SIRPB1 DCC PLG QKI WNK3 KPNA1 ADNP2 GRM4 PBRM1 TRMT2A CTCF PRKCA RIMS2 | 1.41e-04 | 883 | 203 | 17 | C0036341 |
| Disease | aspirin use measurement | 1.48e-04 | 39 | 203 | 4 | EFO_0007013 | |
| Disease | Malignant neoplasm of breast | ERCC6 WNK1 GDF10 CIC GGA3 ZCCHC14 ELAPOR1 UTP20 PLD2 ZNHIT2 NCOA2 COL7A1 FN1 CAT PBRM1 TRMT2A ROBO1 LSP1 SPEN | 1.70e-04 | 1074 | 203 | 19 | C0006142 |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.03e-04 | 17 | 203 | 3 | EFO_0022232 | |
| Disease | mean corpuscular hemoglobin concentration | MAG SP1 GATAD2A BACH2 DAG1 GON4L IREB2 KLHL29 NEO1 CC2D2A KPNA1 VIL1 KHDRBS2 EBF1 BRF1 CTCF BRD4 MAST1 PKN2 | 2.43e-04 | 1105 | 203 | 19 | EFO_0004528 |
| Disease | Herlitz Disease | 2.80e-04 | 4 | 203 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 2.80e-04 | 4 | 203 | 2 | C0079297 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.83e-04 | 46 | 203 | 4 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | platelet crit | SP4 GATAD2A BACH2 DAG1 SIRPB1 C2CD5 SIRPG KLHL29 RBM27 NCOA2 SLC4A7 SCAMP1 LPIN3 TRABD LPA DCHS1 PKN2 | 3.38e-04 | 952 | 203 | 17 | EFO_0007985 |
| Disease | visceral adipose tissue measurement, body mass index | 3.43e-04 | 87 | 203 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | stroke, coronary artery disease | 3.89e-04 | 21 | 203 | 3 | EFO_0000712, EFO_0001645 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 3.89e-04 | 21 | 203 | 3 | EFO_0022246 | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.22e-04 | 51 | 203 | 4 | EFO_0022240 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 4.65e-04 | 5 | 203 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 4.65e-04 | 5 | 203 | 2 | C2608084 | |
| Disease | plasma plasminogen measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0006309 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 4.65e-04 | 5 | 203 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 4.65e-04 | 5 | 203 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in small LDL percentage | 4.89e-04 | 53 | 203 | 4 | EFO_0022286 | |
| Disease | triglycerides in medium HDL measurement | 5.26e-04 | 54 | 203 | 4 | EFO_0022321 | |
| Disease | neuroticism measurement, cognitive function measurement | HIVEP1 DCC FCHO1 KLHL29 ZCCHC14 PTPRK JADE2 PCLO PCDHA12 PCDHA7 PCDHA5 PCDHA4 | 5.92e-04 | 566 | 203 | 12 | EFO_0007660, EFO_0008354 |
| Disease | free cholesterol to total lipids in large HDL percentage | 6.04e-04 | 56 | 203 | 4 | EFO_0022279 | |
| Disease | large artery stroke, coronary artery disease | 6.60e-04 | 25 | 203 | 3 | EFO_0001645, EFO_0005524 | |
| Disease | low density lipoprotein particle size measurement | 6.90e-04 | 58 | 203 | 4 | EFO_0008593 | |
| Disease | Junctional Epidermolysis Bullosa | 6.94e-04 | 6 | 203 | 2 | C0079301 | |
| Disease | C-C motif chemokine 22 measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0020196 | |
| Disease | angiostatin measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0008024 | |
| Disease | triglycerides to total lipids in small LDL percentage | 7.36e-04 | 59 | 203 | 4 | EFO_0022337 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 7.86e-04 | 157 | 203 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | free cholesterol in very large HDL measurement | 8.88e-04 | 62 | 203 | 4 | EFO_0022273 | |
| Disease | lysophosphatidylethanolamine 22:6 measurement | 9.26e-04 | 28 | 203 | 3 | EFO_0010371 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 9.43e-04 | 63 | 203 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 9.43e-04 | 63 | 203 | 4 | EFO_0022239 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0020797 | |
| Disease | catalase measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0008071 | |
| Disease | cigarettes per day measurement | 9.68e-04 | 438 | 203 | 10 | EFO_0006525 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 9.82e-04 | 225 | 203 | 7 | EFO_0008317, EFO_0010351 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.00e-03 | 64 | 203 | 4 | EFO_0022253 | |
| Disease | triglycerides in small LDL measurement | 1.06e-03 | 65 | 203 | 4 | EFO_0022323 | |
| Disease | total lipids in very large HDL measurement | 1.12e-03 | 66 | 203 | 4 | EFO_0022312 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.19e-03 | 67 | 203 | 4 | EFO_0022245 | |
| Disease | red blood cell density measurement | SP1 SP4 HIVEP1 BACH2 WNK1 CIITA CC2D2A VIL1 KLF11 RFX7 PBRM1 BRF1 MICALL2 BRD4 PKN2 | 1.20e-03 | 880 | 203 | 15 | EFO_0007978 |
| Disease | aortic stenosis | 1.25e-03 | 31 | 203 | 3 | EFO_0000266 | |
| Disease | free cholesterol in large VLDL measurement | 1.26e-03 | 68 | 203 | 4 | EFO_0022265 | |
| Disease | osteosarcoma | 1.28e-03 | 8 | 203 | 2 | EFO_0000637 | |
| Disease | Neonatal sepsis | 1.28e-03 | 8 | 203 | 2 | HP_0040187 | |
| Disease | female breast cancer (is_implicated_in) | 1.28e-03 | 8 | 203 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.33e-03 | 69 | 203 | 4 | EFO_0022341 | |
| Disease | cholesterol in very large HDL measurement | 1.33e-03 | 69 | 203 | 4 | EFO_0022229 | |
| Disease | hypertension | 1.36e-03 | 307 | 203 | 8 | EFO_0000537 | |
| Disease | pulse pressure measurement, alcohol drinking | 1.40e-03 | 70 | 203 | 4 | EFO_0004329, EFO_0005763 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.47e-03 | 71 | 203 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | Abnormality of the face | 1.64e-03 | 9 | 203 | 2 | C4025871 | |
| Disease | familial Mediterranean fever (is_marker_for) | 1.64e-03 | 9 | 203 | 2 | DOID:2987 (is_marker_for) | |
| Disease | signal-regulatory protein beta-1 measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0802069 | |
| Disease | neuroticism measurement | SETD1A SP4 HIVEP1 DAG1 DCC KLHL29 ZCCHC14 BAG6 KLF11 PCLO LMTK2 ATF6B MBNL2 PRKCA IGSF21 | 1.65e-03 | 909 | 203 | 15 | EFO_0007660 |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.72e-03 | 74 | 203 | 4 | EFO_0022280 | |
| Disease | angina pectoris | 1.77e-03 | 125 | 203 | 5 | EFO_0003913 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.81e-03 | 75 | 203 | 4 | EFO_0022287 | |
| Disease | cortical thickness | MON2 SP1 GATAD2A GDF10 KLHL29 NEO1 CEP120 UBN1 WNK2 NCOA2 HSPG2 CHSY1 EBF1 ADAMTS8 RAB44 CBY2 ROBO1 | 1.87e-03 | 1113 | 203 | 17 | EFO_0004840 |
| Disease | body composition measurement | 2.26e-03 | 193 | 203 | 6 | EFO_0005106 | |
| Disease | hepatocyte growth factor-like protein measurement | 2.27e-03 | 38 | 203 | 3 | EFO_0008154 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 2.44e-03 | 39 | 203 | 3 | EFO_0008298 | |
| Disease | polymyositis (is_marker_for) | 2.49e-03 | 11 | 203 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | Antihypertensive use measurement | 2.49e-03 | 265 | 203 | 7 | EFO_0009927 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.50e-03 | 82 | 203 | 4 | EFO_0008535 | |
| Disease | Abnormality of refraction | GALNT15 BMP3 QKI PRRX1 PCLO PCDHA12 PCDHA7 PCDHA5 PCDHA4 EBF1 LATS2 ROBO1 | 2.55e-03 | 673 | 203 | 12 | HP_0000539 |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.63e-03 | 40 | 203 | 3 | EFO_0004746 | |
| Disease | Mesothelioma | 2.82e-03 | 41 | 203 | 3 | C0025500 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 2.82e-03 | 41 | 203 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | post-traumatic stress disorder | 2.83e-03 | 202 | 203 | 6 | EFO_0001358 | |
| Disease | depressive symptom measurement | 2.90e-03 | 426 | 203 | 9 | EFO_0007006 | |
| Disease | aortic stenosis, aortic valve calcification | 3.02e-03 | 42 | 203 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 3.02e-03 | 42 | 203 | 3 | EFO_0022255 | |
| Disease | myocardial infarction | 3.06e-03 | 350 | 203 | 8 | EFO_0000612 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 3.23e-03 | 43 | 203 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.23e-03 | 43 | 203 | 3 | EFO_0022290 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.26e-03 | 144 | 203 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Diabetes, Autoimmune | 3.45e-03 | 44 | 203 | 3 | C0205734 | |
| Disease | Brittle diabetes | 3.45e-03 | 44 | 203 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 3.45e-03 | 44 | 203 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 3.45e-03 | 44 | 203 | 3 | C3837958 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 3.49e-03 | 13 | 203 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Takayasu arteritis | 3.67e-03 | 148 | 203 | 5 | EFO_1001857 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 3.68e-03 | 45 | 203 | 3 | C0011854 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.68e-03 | 45 | 203 | 3 | EFO_0022236 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRAVPGPQSPGTVVI | 191 | B0FP48 | |
| GAPVTTVPVPNRLAV | 391 | Q8IVW6 | |
| TVPVPNRLAVPVTLA | 396 | Q8IVW6 | |
| LTLIPGPVEPFSIVT | 471 | Q8NFU1 | |
| ERGPPLEPRSQTVTV | 806 | Q9BYV9 | |
| SIVRAVGVVPGIPEP | 421 | P12645 | |
| TVPPVLPAALTIGNV | 441 | Q4VNC0 | |
| VPPQEGVPARLPAVV | 276 | P19419 | |
| GELQLVQVPVPVTVP | 111 | P49711 | |
| VITVGPRGPLLVQDV | 41 | P04040 | |
| VVPQEPSSVVGLGPR | 231 | Q76N32 | |
| TPGPVIQVPEASVTI | 136 | Q68CJ9 | |
| QVPGFPTAPTRVVIA | 491 | P46379 | |
| IATQVPVLEPQLPGS | 801 | O60885 | |
| REQEVPPVIITETPL | 91 | Q9H568 | |
| EQPGPSIPRAIVESV | 266 | Q9H568 | |
| AEPPTVVTGSLLVRP | 161 | P33076 | |
| LTVQLLTVPGEVFPP | 786 | Q9UP79 | |
| DVVLPVFGTPRTPQI | 46 | Q6UY09 | |
| PPIITKPERVVGVIG | 141 | Q14833 | |
| IRVQTPPRHIPGVVE | 301 | Q9HAK2 | |
| TVILPESVFRETPPV | 2201 | Q9HCU4 | |
| VELVPPTPAEIPRAI | 36 | O75964 | |
| VGGVIRQLPPTVVKP | 1886 | Q2TAZ0 | |
| VELVPPTPAEIPRAI | 36 | Q7Z4Y8 | |
| PGVVPRTFLGPVVIA | 61 | Q9BV10 | |
| SQPVVSGVLPVGQPV | 546 | Q6IQ32 | |
| PERIPVTVLPPEAIT | 181 | O95072 | |
| RAANIVIQTEPPVPV | 531 | Q9P2N5 | |
| PLVVEVHPARSIVPQ | 1676 | P98160 | |
| VLVTIEASVIPGPIP | 2231 | P98160 | |
| EASVIPGPIPPVRIE | 2236 | P98160 | |
| TAQAAPRIITGPAPV | 221 | Q96PU8 | |
| PQTPRVVRQISISEP | 401 | Q7Z6P3 | |
| FPDVVLVRVPTPSVQ | 66 | Q8IXN7 | |
| IVPSVSGPKRPQDRV | 441 | P48200 | |
| EQSPQPTIPIVGIVA | 296 | P30511 | |
| IPDVTIPPSIAQLTG | 456 | Q8IWT6 | |
| DLTVQPVAGRVTAPP | 586 | P0DP91 | |
| PVITAPPLINGTAEV | 561 | Q8TAB3 | |
| IIPGSPAIISIRQEP | 876 | Q9UN72 | |
| TVTTPPPLVRGTQNI | 186 | Q86YP4 | |
| VPTPLTNVQILLPVG | 781 | O14526 | |
| VPDRVPPGTLVTTLQ | 1226 | Q96JQ0 | |
| ERDPAAPVPVVLTVT | 1326 | Q96JQ0 | |
| DRGQPPQSSVVPVTV | 2576 | Q96JQ0 | |
| SVLPSAPRDVVPVLV | 426 | P43146 | |
| LEVPVPTGQPERVSR | 351 | Q9BQK8 | |
| VPENLPVGTPVLAVT | 251 | Q9Y5G7 | |
| VPRDVPLPVVRVASV | 1086 | Q86U86 | |
| IRSPGILPVIQPVVV | 136 | P57682 | |
| LQVEPPEPVVAVALG | 26 | Q13477 | |
| GVVPAGVILERSQPP | 281 | Q14676 | |
| PNIVVPPEVVAGTEV | 141 | P20916 | |
| TVPGQAPRLAVAVPA | 266 | Q5XG99 | |
| IPVPVTEALEVQGPV | 3311 | Q16787 | |
| GPSPVPSVVRTEIFL | 396 | Q6PXP3 | |
| SVRVLRPEPQTAVGP | 446 | Q9NRM7 | |
| EEPPGQSRAPVLTVV | 581 | Q96H55 | |
| IAGPREPPTQVSVVQ | 2266 | Q8NDA2 | |
| LVVQVPPVIENGLPD | 4026 | Q8NDA2 | |
| GPETPIQVVLRVRPM | 21 | Q96FN5 | |
| ENPVPLTVRVSPEVR | 316 | Q8N1G4 | |
| ILTLVVPGFRPPQSV | 471 | Q6UXG2 | |
| DPIPGRQSTAVQPLV | 1701 | Q9UPA5 | |
| ASPTENGQVLRVIPP | 106 | Q8N187 | |
| IIQTPTLGPIQPTRV | 376 | Q14118 | |
| QSIVRAVGIIPGIPE | 426 | P55107 | |
| ISPIRSPVVPGEVVA | 356 | Q8N3T1 | |
| LPDVGAVQTLQPPRT | 316 | A6NNH2 | |
| VPAGAEAIPEPVVRI | 91 | Q9NQC1 | |
| VPALPGETVTSPVRL | 716 | Q8IY33 | |
| VEPVFSVVPPVTAVE | 2616 | Q9Y6V0 | |
| TNPRITEIIPVTGPR | 856 | Q9HCM2 | |
| PAPGRVNVVSPSLEV | 266 | Q32MK0 | |
| AIIPDPVVAPSIVPV | 556 | Q12996 | |
| LRVVPLGIPPGTQTL | 41 | Q50LG9 | |
| GQDVPLRVPGVVPVF | 526 | Q8IWU2 | |
| QGIVQSDPPIPVDRT | 141 | Q9NZ52 | |
| ECPPGRPDVLVVVVS | 616 | Q9NZ52 | |
| VIPVTQETVVLPLPI | 1246 | Q6ZVL6 | |
| LRPIPITASVEIQEP | 616 | P23229 | |
| ETPPVVNVPVPVLIG | 1186 | Q7Z3U7 | |
| IPGSPAIISIRQEPT | 876 | Q9Y5H7 | |
| GILQPRPIPAGETVI | 371 | Q9C091 | |
| RPIPAGETVIVPENL | 376 | Q9C091 | |
| IPIIPDIPIVDAQSG | 1326 | P16144 | |
| VDIPENRVILITPTP | 121 | Q2TAA2 | |
| IVVEPARPGAKAVVP | 1436 | Q9Y2H9 | |
| VVIEGTLEPARPPQT | 301 | Q9BYG4 | |
| TEPTISQELGQRPPV | 2046 | P16112 | |
| IDVLVPPTIIGTNFP | 1446 | Q96RW7 | |
| LPFAVPITTVVGRPI | 281 | Q86VF5 | |
| GAPVRLVAPAPVIIS | 576 | Q14671 | |
| VPRVAPGIISAQQSP | 246 | O43316 | |
| PMGLPEIRQVPTVVI | 356 | Q9C0D0 | |
| IIPGSPAIISIRQEP | 946 | Q9Y5I4 | |
| PQVELVVSRPIGDIP | 746 | Q9UQ26 | |
| IIPGSPAIISIRQEP | 886 | Q9UN74 | |
| PIEIIQADSPPIIVG | 241 | Q8N6M0 | |
| ISVVLPQRGTAEPFP | 46 | Q8NA61 | |
| TSRLPAGQVPVTLQP | 181 | Q9YNA8 | |
| SRSGEPVRNPKIVVP | 326 | Q14549 | |
| LTVNIEPLPPVVAGD | 26 | Q96ID5 | |
| PIPETTVVTGRAPTE | 746 | Q9P2K1 | |
| LAPIPVELAPTVGVS | 321 | Q8N960 | |
| VQTPPRHIPGVVEVT | 306 | Q9BQW3 | |
| PQALREVSPVEIPGQ | 21 | A6NGS2 | |
| SVPISDTIIPEVPQL | 1256 | P02751 | |
| ATVLQTVPGVPPLGV | 1046 | Q3T8J9 | |
| TAPSVIPPAVERVQP | 351 | Q5T0F9 | |
| IPVFGIVPAIIQTPS | 581 | Q13443 | |
| TEGTVVAPPTVIQVP | 1696 | P08519 | |
| RVQTPPRHIPGVVEV | 311 | Q9UH73 | |
| TPPRVISAVIKGPEV | 521 | Q15723 | |
| VGLVPTEILPTTPVI | 141 | Q5VZF2 | |
| ATIDILVIERPGPPQ | 136 | A2RUH7 | |
| QVVEVPGVPSRPASV | 36 | Q8N2S1 | |
| QQPRTPSPLVLEGTI | 171 | P33241 | |
| RNVTVGPPENIEVTP | 136 | P38484 | |
| STVTRGALPVPPVAR | 226 | Q5VWX1 | |
| VVVPRGTPTPRGVLS | 216 | O75525 | |
| PPQLSVGTVRPILAQ | 306 | O14901 | |
| FIIQEATTLVPGIPP | 66 | P06315 | |
| TVPVPQVDIVPGRLS | 26 | A6NN90 | |
| REGTPVSIVVTTPPE | 851 | Q02388 | |
| DRGVPPLRTPVSIQV | 1041 | Q9NYQ7 | |
| IRVQTPPRHIPGVVE | 311 | Q9H4W6 | |
| LVTSIALGRPVPQPL | 2116 | Q9BYK8 | |
| APVVQVPGRLFPITV | 326 | Q14147 | |
| LQSTPRPLQEEVPVV | 41 | Q7Z3Z3 | |
| SISRPPPVDVRDVVG | 1026 | Q9UPN6 | |
| GPREASPLVVISQPA | 566 | Q9P1Z2 | |
| ISEEIIGSPIPEPRQ | 636 | Q86YS7 | |
| VPIVFTPVVPGDVQA | 761 | Q9C0B2 | |
| TIIQTDEDVPGPVPV | 481 | Q15262 | |
| IPGSPAIISIRQEPT | 881 | Q9UN75 | |
| PPAVDAVVGQIVPSI | 851 | O15397 | |
| IVLPSVVPLVPAGTV | 326 | A6ND36 | |
| RTEVGPVKPPQAQTL | 86 | A1L443 | |
| RTEVGPVKPPQAQTL | 86 | Q5VZR2 | |
| LTLEPDPIIVPGNVT | 51 | P17900 | |
| VQAPGTPIIARQVTP | 506 | O00268 | |
| GVQPPVVTVLEPDAV | 2726 | O75445 | |
| LVRVLVSPTNPPGAT | 286 | O60763 | |
| VVQTAVPDGPLQEVP | 706 | O75691 | |
| NQTVPVQIRPGVSIP | 226 | Q02446 | |
| SEPPVTRVADVVTPL | 161 | Q8IZ69 | |
| LRAVPGPQSPGTVVI | 191 | E5RIL1 | |
| PAVLLTGLTEVPVPT | 451 | Q9Y6M7 | |
| PLEVTLTQPVRSGPV | 56 | Q7Z736 | |
| ETREAVPQPTVPLGT | 796 | B4DYI2 | |
| PVTIPSVGVVNPILA | 391 | Q9UHX1 | |
| IVGEIQRGFPTPVSP | 311 | Q7LBE3 | |
| VIVPKGSQLGPVPVT | 616 | A6NFQ2 | |
| TRGQPVLTPPDQLVI | 631 | P17252 | |
| TVFVPLTVIPVPSLE | 111 | Q16609 | |
| PPIDEVISTPGVVAR | 116 | P52294 | |
| PVRVVIPRGSILDPS | 1056 | O14841 | |
| TVRPITLVPAPGTQF | 181 | Q7Z3K3 | |
| APLRVETQPEVQLPG | 526 | Q92859 | |
| PEVEGTLIRVPIPQV | 171 | Q96E11 | |
| TIPIVQAVPQGAETP | 321 | Q2M3G4 | |
| PSVTQVTRNVPPGLD | 21 | O15126 | |
| PQAPVPTTVPVVDVR | 536 | Q16513 | |
| PTTVPVVDVRIPQLA | 541 | Q16513 | |
| IVVRQAPRDGLTPVP | 1311 | Q6ZRS2 | |
| QAVPNSGPIIIRTPT | 441 | P08047 | |
| GTEASVVAPPPVVLL | 456 | P00747 | |
| EAIRVPPTLEVTQQP | 246 | Q9P1W8 | |
| SLVEPQIPGISIPTD | 926 | Q9Y2L1 | |
| PVEVPVPERVAGSPV | 1091 | O15047 | |
| IAGIPTVPVPGVREE | 161 | Q9BR10 | |
| VPPTLEVTQQPVRAE | 251 | Q5TFQ8 | |
| PPVSPVVLIQGAIRV | 276 | Q99941 | |
| VLAATAPTPGIPILQ | 876 | Q96RK0 | |
| DTSVPIPVVPLRGVD | 126 | Q86X52 | |
| VNLTLRPGVPTQAPI | 1216 | Q15596 | |
| GRDSPPTITIPVNIN | 3056 | A4UGR9 | |
| VPTEGVRLVPPQVNK | 11 | Q6ZS11 | |
| PVEVPVAVPVVEAVP | 1261 | O15417 | |
| PSGRDPETPIIVVKQ | 686 | P09327 | |
| VPPVVPAQTVRQLVE | 71 | Q96K62 | |
| PVNVLTGPVNVLTTP | 2696 | Q96T58 | |
| LPLTPPVVVTHGVQI | 3281 | Q96T58 | |
| SPPPDGTEQVIISRV | 646 | Q9BZQ8 | |
| PDPVRVVSIGVPVSE | 691 | P49588 | |
| ETVLQQPAILPSGPV | 191 | Q9UNN4 | |
| PVVPSEASEPVPRVL | 16 | Q9H4I3 | |
| PAVEAPAVGIQVPQV | 281 | Q9BXM0 | |
| PAVGIQVPQVELPAL | 286 | Q9BXM0 | |
| RPPVTTSNAIPPAVV | 276 | Q9H0E3 | |
| QPAVALSTIPGAVPI | 736 | Q9H0E3 | |
| TRVTTPAQRGKVPPV | 161 | O60667 | |
| VSPPPSVITQENLGR | 321 | Q9C0C9 | |
| NPSILSPQPIGIVVA | 251 | Q2KHR2 | |
| GIVVAAVPSPIPVQR | 261 | Q2KHR2 | |
| TDVIADRPPPVIRQG | 446 | Q9Y6N7 | |
| IIPSRGPPGTEIEIT | 1921 | Q86WI1 | |
| PREASARVVVPIAPT | 111 | A8MZF0 | |
| PARPQAVLVESGPVS | 621 | Q92994 | |
| VQISVPPAIINPRTA | 661 | Q8WYQ9 | |
| GACTPVVPTRIPAIV | 186 | Q9UHR6 | |
| NSLGIITPVPIPVHV | 1041 | Q9NPG3 | |
| RVLVVPVTPIPTFQL | 16 | Q96RP3 | |
| VDPQPSVVTRVVNLP | 6 | Q99541 | |
| TAQGLLPVPVPAVVS | 1081 | Q5SXM2 | |
| QIQGVTPLAISVIPP | 1676 | A6NGW2 | |
| VTVVESDPRPQGQPR | 2041 | Q5VWN6 | |
| PSPGSRVLTILEQIP | 391 | Q8NHP8 | |
| VLVGTTIRLPLVPIP | 201 | Q86VR7 | |
| LPLGTVALPVTPVVT | 1716 | Q9H4A3 | |
| VALPVTPVVTPGQVS | 1721 | Q9H4A3 | |
| VVPSVPQDVPAFVRP | 1706 | Q9Y3S1 | |
| DVTAVEQPIVPRPAP | 171 | P54821 | |
| DTNQVVRILPPGEVP | 1421 | A3KMH1 | |
| GPSVEPGSIVPQIVL | 346 | Q8IWU6 | |
| PLVFAPGVPVTAQVV | 56 | O14939 | |
| LTVGQVRPLVPLQPV | 266 | Q99959 | |
| SSVVPCIPIGQIRVP | 2461 | P15822 | |
| PQRLGVLITPVPDAQ | 321 | P78423 | |
| LLPVPAVRGVAETPT | 21 | O95407 | |
| SGVQLQPLRPAPEVT | 816 | Q5EBL2 | |
| VLPVHVLGPTVVSQP | 651 | Q9BYP7 | |
| VLGPTVVSQPQVSPL | 656 | Q9BYP7 | |
| VNVQAPVIGVTPSLP | 176 | Q96CT2 | |
| ERGPAVVPVVPVAPE | 76 | Q6PF15 | |
| TVVTPVIEQILPDSP | 141 | P53667 | |
| VIPPLPSRNEVVPAT | 356 | E9PAV3 | |
| ISPGQIIDEPIRPVN | 1451 | Q9Y4I1 |